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61. Abstract
The risk of developing Type 1 diabetes depends on the action of a number of genes in
combination with environmental factors. The pathogenic process is unknown, but at the
time of diagnosis the autoimmune destruction of the insulin producing beta cells of
pancreas has proceeded to a level where an individual is unable to survive without insulin
replacement therapy. Type 1 diabetes is the second most common chronic disease of
children in Finland, with approximately 0.4% of total population being affected. The
incidence is one of the highest in the world and is continuously increasing. The reasons
for the upward trend in the incidence are not known. The main predisposing genetic
region for Type 1 diabetes is the HLA locus on chromosome 6p21.3 (IDDM1). Recent
genome scans have identified non-HLA loci linked to Type 1 diabetes, with much weaker
effects than IDDM1. More accurate identification of the genes and of the DNA variants
involved will lead to a better understanding of the disease.
The first part of this thesis is concerned with incidence trends: a survey of global
incidence trends revealed strong evidence for a global increase. A hypothetical genetic
explanation for the increase was given and studied, namely the possibility of non-
Mendelian transmission of diabetes susceptibility alleles, increasing the pool of
predisposing alleles in the population. The transmission probabilities of HLA A, B and
DR alleles from parents to offspring were estimated from a nationwide Type 1 diabetes
genetic epidemiological study carried out in Finland. Existence of strong non-Mendelian
transmission could be ruled out, but minor deviations in the transmission probabilities
may still be possible. A simple population model for the effects of modest transmission
distortion on the incidence showed that this mechanism alone could not be the cause for
the observed trend.
The second part of the thesis is concerned with the development of new methods for
finding complex disease loci, with special applications to Type 1 diabetes. Data mining
algorithms were used for linkage disequilibrium mapping (Haplotype Pattern Mining,
HPM). The approach enables one to find loci even with strong allele and locus
heterogeneity and associated low penetrances, which are expected in complex diseases,
given that there are a sufficiently small number of founder disease alleles in the
population. The method was applied to real data from Type 1 diabetic families from the
UK, where the known susceptibility gene was accurately localized with less data than had
previously been used by alternative methods. The presented studies demonstrate the
advantages of utilizing the data mining approach in complex trait mapping.
72. From epidemiology to gene mapping
2.1 Epidemiology
Complex diseases, such as diabetes, asthma, or coronary heart disease, have long been a
focus of epidemiological and clinical research. These diseases are common, they affect
both the life quality and life expectancy of patients, and they exert great demands on
health care system. The pathogeneses of these diseases are complex, presumably
involving both genetic and environmental risk factors.
Epidemiology focuses on patterns of disease occurrence in populations and the
factors that influence these patterns. The basic measures of disease frequency are
incidence, prevalence and cumulative incidence (Table 1). The study of the occurrence of
diseases helps in formulating possible roles for different etiologic factors. The factors are
either known from previous studies, or they may simply be educated guesses based on
clinical work. When associations are found, the next step is the assessment of the
biological mechanisms behind them. Due to the very nature of the study questions, the
field is closely connected with statistics.
Table 1. The basic epidemiologic measures of disease frequency. Adapted from
Khoury et al 1993.
Incidence Cumulative
incidence
Prevalence
Numerator Number of new
disease onsets
Number of new cases
in a period of time
Number of cases at a
point of time
Denominator Total time of exposure Size of population at
the start of
observation
Size of the population
at same point or
period of time
Examples Birth rates, disease
incidence
Lifetime risk,
penetrance
Allele and genotype
frequencies
The patterns of disease occurrence describe the disease at the population level, for
instance geographical clustering, but they can also be used to direct genetic research to
concentrate on specific subpopulations, e.g. population sub-isolates. Studies on
prevalence and incidence may tell us, for example, the maximum number of affected
individuals available for a genetic study. Geographic enrichment in the disease
prevalence across the population may imply either some environmental or genetic factors
increasing the susceptibility in the high prevalence areas. Furthermore, the accumulation
8of disease in families and pedigrees can be used, for example, to estimate whether a
sufficient genetic component exists to be found by a genetic study.
While epidemiological studies will continue to be an indispensable tool for
research into common complex diseases, considerable efforts in finding the actual
biological causes of common complex diseases have been made during the passed
decade. By utilizing the technique of positional cloning, supplemented with advanced
statistical methods, geneticists are now, starting to disentangle the genetic factors behind
the complex diseases. The search for genetic factors is based on studying the observed
correlations between genetic markers and disease, in either population-based samples of
affected and healthy individuals, or pedigrees sampled on the basis of disease occurrence
in the pedigree members. The task is twofold: 1) to find genetic regions where the
susceptibility loci are most probably located, 2) to assess the effects of specific
susceptibility loci, alleles and genotypes on the phenotype. The discipline concerned with
these questions is called genetic epidemiology.
Luckily for the geneticist, the Finnish population history makes it genetically less
complex than most other populations. This gives a hope that the genetic basis for
multifactorial traits might be less variable in Finnish people than in groups with more
mixed ethnicities. Furthermore, registries such as the Finnish population registry, the
National hospital discharge registry, the drug reimbursement registry, and the diabetes
registry at the National Public Health Institute, provide reliable sources of information for
scientists. Even on a global scale, they provide excellent opportunities for population-
based, extensive family studies.
2.2 Genetic epidemiology
Genetic epidemiology is defined as ”the study of the role of genetic factors and their
interactions with environmental factors in the occurrence of disease in human
populations” (Khoury et al 1993). Genetic epidemiology stands at the cross-roads of
genetics and epidemiology, having borrowed its basic concepts and methods from both:
its statistical methodology derives from traditional epidemiology, while the main force
driving the development of new methodology is the rapid advance of laboratory methods
in genetics. Though still remote, the final objective of the discipline is disease control and
prevention.
There are basically two kinds of approaches to study the role of genetic factors in
disease. First, the study questions set by a genetic epidemiologist may be something like
“what is the rate of the condition at birth in certain population, and can one estimate the
mutation rates for this autosomal dominant condition?” Or “what are the geographical
differences in the frequency of a genetic trait?” Second, but even more important, is the
study of inheritance of traits in families. By using family studies the researcher tries to
find out whether diseases cluster in families, whether the possible familial clustering is
related to a common environmental exposure, biologically inherited susceptibility, or
perhaps life style related risk factors. Or, a question might be “what is the genetic model
for a trait?”
9Genetic epidemiology brings together the methodologies of epidemiology and
genetics. While the former has sought answers to the questions formulated above by large
population-based studies, concentrating on finding weak effects in large masses of data,
the latter has traditionally sought for strong gene effects in rare monogenic diseases with
carefully ascertained pedigrees. When it comes to modern day disease genetics, the
interest is now in finding the moderate to weak gene effects. Thus, the statistical
approaches of modern day epidemiology, conjoined with effective ascertainment schemes
relying on solid knowledge of medical genetics, is the core of the methodology of genetic
epidemiology. The segregation, linkage, and heritability analyses (Table 2) all use
pedigree data but, through extensive modelling of the data, look for small, inherited
effects in disease. The methods will be explained in detail in the chapter 2.5.
Recently, much effort has been put into developing association and haplotype
analyses. They utilize population-based association of genetic markers to traits, either
because of the direct effect of the polymorphism on the phenotype, or due to linkage
disequilibrium (LD, non-random association of alleles in nearby loci) of a marker locus
to a close disease locus. A good understanding of effects of population history is central
to understanding the nature of LD. It seems, therefore, that there is an important role for
population genetics in the new gene mapping methodology.
The use of computationally intensive methods for gene mapping has become
possible by the rapid progress of in computer technology. Technical development has
been fast, but the need for even more efficient computers still persists, as the statistical
models are also evolving to become more and more complex. In the coming years, the
amount of genetic data is expected to explode, as new high-throughput marker typing
machinery is introduced. This will set heavy demands on the computational methods used
for analysing such data, as the prevailing statistical methodology is computationally very
intensive. Furthermore, a growing need for ”integrated approaches” exists; to
simultaneously utilize linkage and association, or to analyse multidimensional instead of
one-dimensional responses. In short, the goal is to utilize the information in the data to its
full extent.
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2.3 Genes in populations
Genes do not exist in a vacuum – rather, they constitute a pool which has been formed by
millions of years of evolution moulded by the processes of mutation, selection,
recombination, and genetic drift. The genetic variation which we see today has its history.
How do the processes shape the allelic diversity? In particular, how do they explain the
existence of hereditary diseases? How does this all impact on gene-mapping trials?
2.3.1 Evolutionary processes
Mutation
New alleles are formed at a gene locus by mutations, such as deletions, insertions, point
mutations, and gene conversion (the interchange of very short stretches of DNA between
homologous chromosomes during meiosis). A mutation may be silent (in the synonymous
site in the codon), it may change a single amino acid, the reading frame of the gene, or
produce a stop codon, creating a non-functional, truncated protein product. Indeed, most
new mutations are slightly deleterious. The overall mutation rates vary between genetic
areas, but for coding genes they typically are low, in the range of 10-7-10-4 per locus per
gamete. Even though rare, the mutation process constantly creates new variation to the
population.
A typical Mendelian trait is observed when a mutation in a single coding gene,
either as one copy (dominant) or two copies (recessive) in an individual is sufficient to
cause a change in phenotype. Today, 9,521 single gene disorders (separate phenotypes
with proved mode of inheritance of the mutation characterized) are known and included
in the OMIM (Online Mendelian Inheritance in Man) database
www.ncbi.nlm.nih.gov/Omim/, see also McKusick (1998). When the alleles of patients
affected by a particular disease have been sequenced, it has often been found that most of
the disease alleles are descendants of the same ancestral mutation, the remaining being
new very rare mutations. A representative example is cystic fibrosis, a common single-
gene disorder with recessive inheritance: two thirds of disease alleles worldwide derive
from the same ancestral mutation dating back to hundreds of generations ago, while the
remaining disease alleles consist of almost thousand independent new mutations (989 in
fall 2001, CF mutation registry, www.genet.sickkids.on.ca/cftr-cgi-bin/FullTable). The
mutations range from point mutations to deletions of different sizes to frame shift
mutations and stop codons, each with a different effect on the protein product: some
mutations change the amino acids in the binding sites, leading to proteins with altered
function, some the efficiency at which the protein works thereby altering the flux in
metabolic pathway. There is a continuum of phenotypes corresponding to these different
mutation effects.
Unlike single gene disorders, the numbers and the types of different mutations
affecting the complex traits are not well known. The few known exceptions include
disease variants which are common in populations in general, and exert only a small
increase in disease risk (the risk of a sibling of an affected person to also become affected
12
is in range λs=1.2-5). For instance, ApoE4 isoform (E4 isoform is an allele class with a
certain coding site substitution), which elevates the risk for Alzheimer’s disease, is found
in 6-37% of subjects in different populations. Similarly, serological specificity class
HLA-Cw6 is associated with psoriasis in all populations. Susceptibility to Type 1
diabetes, is conferred by a common serological specificity HLA-DQ8, which is associated
with diabetes all over the world. The debate is, however, still not finished about the
nature of disease polymorphisms: the main hypotheses are the Common Disease/
Common Variants and multiple rare variants (Zwick et al 2000). According to recent
observations that indicate a prominent population bottleneck in Caucasians approximately
50,000 years ago, and also, predictions of allelic spectra in human diseases, based on a
population genetic model (Reich and Lander 2001) it is more likely that the former
hypothesis is true (Reich et al 2001).
Natural selection
The fate of a new mutation naturally depends on its effect on the phenotype. The
phenotypic effects are “tested” by natural selection. In broad terms, selection works on
the abilities of different genotypes to transmit genes to the next generation. This ability is
often called fitness, and is defined by w = 1±s, where s is the fraction by which the
individual’s genotype is superior (or inferior) to the prevailing genotype with fitness 1.
Selection can function at two stages: it may change the properties of individuals surviving
ability, or alter their reproductive success, or do both. It should be noted that the selection
actually works over whole population: for an individual the factors affecting success in
reproduction depend on multitude of factors other than just one gene, but on average
carriers of a certain genotype do slightly better (or worse) than carriers of a reference
genotype. The effect of directional selection is to gradually fix allele with higher fitness.
Natural selection has relevance even to modern human genetics: modern humans
live in a grossly different environment to our ancestors, and we have developed diseases
related to the lifestyle. Nutrition, in particular, has been revolutionized in the course of
just a few generations. Genes that helped early humans to survive through periods of
famine now cause obesity and associated diseases, with the modern diet and increased
lifespan (for instance the Type II diabetes and ‘thrifty’ genotype hypothesis as suggested
by Neel 1962). There are probably several such genes with a beneficial effect at a certain
developmental stage, but which exert deleterious effects on the health later in life. There
has not been any inherent selection against these genes, so that their frequencies may be
very high even today. The deleterious effects can be observed as late-onset diseases only
now that the average lifetime has substantially increased. Proof of natural selection acting
on human populations is difficult to obtain – the well-known exception is sickle-cell
anemia and malaria: the sickle-cell allele in β–globin locus produces severe anemia in the
homozygous condition, while normal homozygous individuals are more susceptible to
malaria. The heterozygotes are protected from both, and thus are fitter (a situation called
heterozygote superiority, or overdominance by population geneticists). The severe
anemia presented by the sickle-cell homozygote genotype prohibits the mutation from
taking over the population. The geographical distribution of the sickle-cell allele follows
the prevalence of the malaria parasite, Falciparum malaria.
Natural selection is also believed to have had a prominent effect on the HLA area
on chromosome six, which is responsible for many immune system functions. The HLA
13
gene family is exceptional compared to other genes: the mutation rates are extraordinarily
high, and therefore the amount of genetic variation is also high. The HLA locus
encompasses approximately 3500 kb of DNA, and is known to harbour at least 150
genes. Furthermore, approximately 80 HLA associations to chronic and infectious
diseases are known (Pile 1999). It has been postulated that the fight against infectious
agents, especially parasites, has directed the evolution of the HLA area, as some HLA
types succeeded better than others in defending the host (de Vries and van Rood 1979, de
Vries et al 1979, Markow et al 1993, Hedrick 1998).
Genetic drift
For every new generation, gametes produced by the previous generation are randomly
sampled to build up the new genotypes. If there are N individuals, 2N gametes are
sampled. The random sampling process allows for changes in allele frequencies which
depend only on N (Figure 1).
Figure 1. The process of genetic drift.
The process is cumulative, in the sense that the sampling for the future generation is
based on the altered gene frequencies of the present generation. This sequence of
cumulative changes is called genetic drift. During the process of genetic drift, some
alleles are lost and some go to fixation (i.e. the fixed allele is the only one present in the
population). For a rare allele variant present only in few copies in the entire population,
the probability of ultimate extinction will be quite high. In fact, the rate of allele loss, or
the expected time to fixation of a neutral allele, can be calculated based on statistical
properties of the sampling process. The probability Ft of autozygosity (i.e. the probability
14
that an individual carries a pair of alleles that are identical by descent) in generation t, is
given by
t
t N
F 


−−=
2
111
(see Hartl and Clark 1989) The smaller the N, the more rapid is the increase in Ft as a
function of t. Obviously, Ft increases with increasing numbers of generations.
The probability of not being autozygous (called allozygosity) is the same as
heterozygosity (if all alleles derived from different ancestors are treated as different
alleles), Ht = 1 – Ft, which after substitution for Ft and approximation by exponential
function yields
Ht ≅ Hoe-t/2N
where Ho is the heterozygosity in the start, if not 1. It is noteworthy that the variability
loss due to the sampling process is quite rapid in small populations – for example, a
population with effective size (Ne) of 40 individuals loses half of its original variation in
about 25 generations, which with a generation interval 20 years yields 500 years. Based
on allele frequency differences between localities in Finland, it has been suggested that
drift has played an important role in the past in small and relatively isolated villages
(Nevanlinna 1972).
Polymorphic equilibria
In a stable population, an equilibrium or steady state may be reached in which the rate of
the formation of new disease mutations at a locus is balanced by random elimination and
natural selection. For neutral polymorphisms, the equilibrium autozygosity is
approximated by
14
1
ˆ
+
=
µN
F
(see Hartl and Clark 1989) where N is the effective population size and µ is the mutation
rate to neutral alleles. The quantity 4Nµ +1 also defines the effective number of alleles in
the population, when it has reached the steady state.
If, on the other hand, the new mutations are deleterious, selection quite rapidly
eliminates them from the population. If the mutation rate at the locus is µ, the equilibrium
frequency of deleterious alleles at the locus can be shown to be
hs
q µ=ˆ (where h is the
degree of dominance, with h = 0 for completely recessive and h = 1 for completely
dominant disease alleles). Thus even lethal one-gene Mendelian conditions, when there is
high enough mutation rate to the disease allele, may persist in populations in low
frequencies even though there is strong selection against them.
15
2.3.2 Population history
Finnish population history
Several, some controversial, theories of the settlement of Finland have been presented
over the years. However, nowadays a plausible view is that the settlement has been a long
process during which small groups of immigrants from the south, east and west have
gradually mixed into the existing main population. The archaeological evidence speaks
for constant habitation starting from the end of last glacial period, and thereafter a gradual
development of agriculture and animal husbandry, of which the earliest evidence dates
back to 3300 to 4000 years ago (Nunez 1987). Linguistic and genetic research indicates a
mixed ethnic origins for Finns. Y chromosome variation in this population shows that
there are two distinct male lineages in Finland (Lahermo et al 1999). The population was
very small over a long period of time, only approximately 5,000 people during pre-
agricultural stage, and still in 12th century no more than 50,000. The coastal areas were
the first to be inhabited. The settlement of the interior started only as recently as the
1500s, when small groups from the area of Savonia migrated into the central and Eastern
parts of the country (Figure 2). Thereafter, the process of emigration and founding of new
communities was repeated several times, from the main villages to new uninhabited
areas, producing several more or less isolated, internal subpopulations (Norio 1966,
Nevanlinna 1972). The structure of these rural sub-isolates has remained amazingly
stable almost to the present times, as most of the migration inside Finland has taken place
from rural areas to cities. The expansion in population size started in 1700s, from
250,000, and is now levelling off at 5,180,000
(www.vaestorekisterikeskus.fi/asukasluku00-01.htm).
16
Population of Finland 1750-1996
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Figure 2. Finnish population history. The southern and coastal areas have been
inhabited for at least several thousands years ago, whereas the central and northern
parts only in 16th century by small emigrant groups from a district in South-East of
Finland, Savonia. Adapted from Norio (2000): Suomi-neidon geenit. Population size
in Finland has grown from less than half a million in 1750 to 5,1 million in 1996
(adapted from Kere 2001).
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It is a well-held opinion - even outside the genetics community - that the Finnish
population history makes this population especially suitable for gene mapping purposes.
The small number of founders, the long period of small population size, and the
expansive growth period starting in 1700s and ending after the Second World War have
characterized Finnish history, and have had a major impact on its gene pool (Nevanlinna
1972). The effects of such events are discussed below. One of the purposes behind
writing this thesis was to understand how the population genetic theory could be utilized
to more efficiently map disease genes in a “founder” population such as Finland.
Population history processes:
Founder effect and population bottle-neck
As noted in the previous section, the effects of random drift are more pronounced in
small populations. This is the basis for founder and bottleneck effects. Founder effects
occur when a small group of individuals settles a new subpopulation: the genetic
composition of the group may deviate from the source population, due to randomness in
the sampling when the group is small, or because the group consists of closely related
individuals (Figure 3). This shift in the genetic make-up of the new subpopulation
compared to the genetic structure of the larger source population is, the founder effect. A
bottle-neck may occur as consequence of the founding or population crash due to a
natural disaster. The bottle-neck is the reduction in population size and thereby, the
reduction in genetic diversity. After the initial settlement of a founder population, the
genetic drift will be the main force acting on the subpopulation when the new population
is small (and immigration negligible). Depending on the length of that time, a number of
alleles may be lost, and some, even deleterious, mutations may by chance be enriched to
high frequencies. An expansion in the population size will then freeze the allele
frequencies to the level they were at the beginning of expansion. This freezing happens
because the effect of genetic drift disappears when population is big enough. In the end,
the genetic constitution of the subpopulation may be quite different from the original
source population, and characterized by population specific alleles.
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Figure 3. Schematic diagram of founder effect and population bottleneck. A few alleles of
the original source population are sampled into the new founder population (upper right
corner), giving rise to founder effect (in the figure, the allele frequency of A’ is elevated
compared to the source population). Thereafter, subsequent genetic drift shapes the genetic
constitution of the new, small population. In the example, the allele a, which is common in
the source population, has disappeared from the offspring population. The source
population, if large and stable, preserves its original variation in approximately the same
frequencies as it had at the time of the separation of the populations.
Many of the consequences of these processes can be observed in the Finnish
population. Finns have quite a unique collection of inherited diseases – there are 36 rare
single-gene disorders classified to belong to the Finnish disease heritage (Norio et al
1973, Norio 2000). On the other hand, some hereditary diseases which are relatively
common in other populations are almost non-existent in Finland, including such well-
known and relatively common syndromes as cystic fibrosis, Huntington’s disease, and
phenylketonuria. Today, all but one of the genes behind the Finnish heritage diseases
have been located and cloned. The focus of research is now turning towards
multifactorial diseases. Thus, the most relevant question nowadays is whether there are
any special advantages – or pitfalls – in genetic mapping of complex diseases in Finnish
population.
Migration
In population genetics, migration describes the movement of individuals, and thereby
their genes, from a population to another population. This exchange of genes mixes the
genetic pool of the populations. Migration reduces the differentiation between
subpopulations, and may even eliminate it entirely. A surprisingly low migration rate,
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approximately 5 % per generation, is enough to completely homogenize subpopulations
(see Hartl and Clark, 1989).
Admixture and stratification
The term ’admixture’ is used to describe a situation where individuals (chromosomes)
drawn from a subpopulation have varying ethnic origins. The most obvious effect of
admixture is genetic heterogeneity.
Stratification, in turn, is a situation where a population is divided into
subpopulations in a non-obvious way, or the origins of people differ widely.
Stratification, when present but undetected in a study sample, may easily lead to false
findings. Several approaches to control and estimate the amount of stratification have
been suggested recently (for example, those presented in Wijsman et al 2001).
2.3.3 Allele frequencies and allelic diversity
The history of evolutionary genetics has been dominated by the struggle between two
competing theories describing the extent and nature of genetic variation. The neutral
hypothesis assumes that most mutations are selectively neutral, with evolution being
driven by mutation and drift, whereas “selectionists” claimed that most polymorphisms
existing today are result of selective forces acting on the newly emerging variation. In the
light of the results from the Human Genome project it seems that the amount of variation
is vast (International Human Genome Sequencing Consortium 2001, Venter et al 2001),
being nearer to the expectations of “neutralists” than those of selectionists.
Several studies on the amount of genetic variation in both coding and non-coding
loci of humans have been carried out (Jorde et al 2000, Eaves et al 2000). The numbers of
alleles per population, and the allele frequency distributions of microsatellite markers are
similarly variable across all populations studied, despite differing population histories.
No significant decrease in heterozygosity has been found even in isolate populations
(Jorde et al 2000, Eaves et al 2000). The same seems to hold true for polymorphisms at
individual SNP loci as well, although there are SNPs, which can be found in some
populations only (called “population-specific” SNPs). There is, however, a potential
difference between non-coding and coding SNPs: the functional relevance of amino acid
altering SNPs may make them targets for natural selection (Cargill et al 1999), but this
has not been proven.
The general observation of similar levels of allelic diversity of genetic markers in
both isolated and large mixed populations has led to the conclusion that there would be
no special advantage in using isolate populations in gene mapping studies (Eaves et al
2000). However, it should be noted that many marker alleles have been common enough
to be transmitted to the Finnish population in a number of copies, even through the
bottleneck. Thus, there has not been enough drift to lose these alleles, or to change their
allele frequencies considerably. Conversely, the disease susceptibility alleles are often
rare, and consequently many have not been present in the founders of the isolate
population at all, but could be new mutations. Drift has eliminated many low frequency
variants of disease alleles, which had originally been transmitted to the subpopulation.
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Thus a great deal of disease allele variation present in the source population should have
disappeared during the history of the isolated subpopulation (Kere 2001). This holds as
well for the single-gene diseases as for complex diseases.
2.3.4 Linkage and linkage disequilibrium
Linkage is co-inheritance of alleles of loci that reside near to each other in a
chromosome. A chromosome passed on to the next generation is a mosaic of maternal
and paternal chromosomes, where the transition points are the points in which crossing
over has taken place. On average, there are 3-5 crossing-overs per human chromosome
per meiosis. Linkage has been extensively utilised in gene mapping: the co-segregation of
a trait with particular marker alleles is evidence of the close proximity of the trait gene.
The genetic distance unit, the centiMorgan (cM), is based on the observed number of
recombination events between loci. Thus, linkage can be observed solely in pedigrees.
Unlike linkage, linkage disequilibrium (LD) can be detected in population
samples. A pair of loci is said to be in linkage disequilibrium when, in a sample of
individuals, their joint haplotype frequencies deviate from those expected under
independence. As an example, consider locus 1 with alleles A and a, and locus 2 with
alleles B and b, at a distance of a few centiMorgans from each other located on the same
chromosome (Figure 4). At equilibrium, the frequency of the AB haplotype should equal
to the product of the allele frequencies of A and B, πAB = πAπB. If this holds, then πAb = πA
πb, πaB = πaπB and πab = πaπb also. Any deviation from these values imply linkage
disequilibrium.
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Figure 4. Linkage disequilibrium between a pair of loci. Locus 1 and locus 2 are
located a chromosome few centiMorgans apart. There are two alleles in each locus,
A and a in locus 1 and B and b in locus 2. If, as in the example, certain combinations
of alleles are much more frequent than others (like A and B, or a and b) there is
linkage disequilibrium in the population.
Linkage disequilibrium may arise for several reasons: a new mutation in locus 1,
producing allele A´ in an AB haplotype in a population comprising of AB and Ab
haplotypes will first show complete LD with allele B, as all A´ alleles in the population
are associated with allele B in locus 2. Recombination will gradually mix the haplotypes
so that at some point allele A´ is joined with b. Eventually the haplotype frequencies will
reach equilibrium values and the LD disappears. The time required for this process
depends crucially on the genetic distance of the A and B loci. The selective advantage of
specific haplotypes, for instance in gene families, might lead to high frequencies of
particular haplotypes and thus be seen as LD between the loci under selection and closely
linked loci “hitch-hiking” withfavored alleles of the selected locus. Recent population
admixture creates situations where strong LD may be found if the admixed populations
are different enough in their allele and haplotype frequencies, and not too many
generations have passed since the original mixing: there are long stretches of DNA in
each chromosomal area with alleles originating from only one population. Undetected
population stratification (if a population has an inner structure which is not known), may
also lead to situation where there is LD between loci. However, these loci may even
reside on different chromosomes.
Linkage disequilibrium should actually be seen as the outcome of a process,
where, on one hand, new mutations, selection, drift and population admixture constantly
create new LD between nearby loci, and on the other hand, recombinations and gene
conversion gradually dilute it. Depending on the relative strength of these forces, the
overall level and the distances to which the LD extends will vary a great deal between
regions of the genome genetic areas and in some part of the genome, between
populations.
Strength of LD
Several studies have been carried out comparing the patterns of LD in human populations
with different population histories using different markers (Reich et al 2001, Eaves et al
2000, Taillon-Miller et al 2000, Abecasis et al 2001). It has been shown that in Caucasian
populations there are approximately twofold amount of LD compared to Africans,
probably due to a severe population bottleneck experienced by Caucasians after they left
Africa (Reich et al 2001). When comparing Caucasian populations to each other,
somewhat more LD is seen in small isolated populations such as Amish, Sardinians, and
Finns, compared to more mixed populations. Saami people have dramatically higher
levels of background LD than Finnish. This LD has probably been produced by genetic
drift in a small, stable population (Ne=6,000) (Cavalli-Sforza and Piazza 1993). A very
recent observation is that in very short distances there is less LD than there should be
based on the minute amount of recombination, for which one possible explanation is gene
conversion (Pritchard and Przeworski 2001, Ardlie et al 2001).
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According to recent studies, it seems that the genome is in fact composed of
blocks of DNA conserved as a group over long stretches of chromosome, up to 100,000
base-pairs, or 0.1 cM (Reich et al 2001). This is at least 10 times longer than was
previously thought (Kruglyak 1999). In a population, there might be as few as two or four
blocks in such an area (Daly et al. 2001). For mapping studies, the practical implications
are that the spacing of markers need not be as dense as was previously estimated
(Kruglyak et al 1999, Helmuth 2001). On the other hand, inside the blocks, increasing the
number of markers does not help in refining the location of a target gene. Extensive
population studies will be needed to further clarify the nature of the block structure and
variation, and potential differences between populations. Currently, a haplotype map
describing the block structure is under construction (Helmuth 2001).
Background LD vs trait-associations
An important distinction must be made between two concepts: the LD between neutral
markers in a population in general, and the LD between neutral markers and a trait or
disease. While the former can be observed in any population sample as background LD,
the discovery of the latter is based on a sample of patients (and controls) in which the
proportion of affected individuals in the sample has been artificially enriched. To be able
to find markers in LD with a disease locus (1) the effect of the disease susceptibility locus
on the phenotype must be strong enough and (2) there must exist a sufficient amount of
LD between the susceptibility locus and markers neighbouring it. In addition to all
evolutionary causes affecting the amount of LD, its usefulness in gene mapping also
depends on the marker density, on the age of the mutation, as well as on the number and
the frequencies of independent susceptibility mutations (each having a unique haplotype
around the mutation).
Measures
A number of different statistics have been used for measuring LD. Most are defined for
either two bi-allelic loci or one bi-allelic marker locus and a dichotomous trait. Those in
most widespread use are D, ∆, δ, d and the χ2-test statistic (Table 3). These measures are
actually all derived from D. Some of these measures are dependent on population allele
frequencies, so that comparisons between different populations cannot be meaningfully
based on observed values of LD. Another drawback is that these point-wise LD values
vary considerably from locus to locus even over very short genetic distances, due to
population history, allele frequencies, and coincidence, and thus do not give a concise
description of the overall LD through a genetic area. Several new methods of LD
measurement have been developed, including multi-marker (haplotype) approaches
allowing for multiple alleles, see chapter 2.5.2.
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Table 3. Statistics for LD. There are two alleles in the two loci, A and a in the first
one, B and b in the second one. πij is used to denote the probability of a haplotype,
πA, πa, πB and πb, the probabilities of a haplotype carrying allele i, as given in the
small table below.
Measure Definition
D aBAbabAB ππππ −
∆
bBaA
aBAbabAB
ππππ
ππππ −
δ
abB
aBAbabAB
ππ
ππππ −
d
bB
aBAbabAB
ππ
ππππ −
χ2
abAB
aBAbabAB N
ππ
ππππ 2)( −
B b
A πAB πAb πA
A πaB πab πa
πB πb 1
2.4 From genes to phenotypes
The etiology of the diseases, from a genetic viewpoint, can be categorized into
single-gene causation, chromosomal causation, multifactorial causation with high
heritability, multifactorial causation with low heritability, infectious causes and
environmental causes.
The biological processes behind phenotypic characteristics differ in their
complexity. In the simplest scenario, phenotypic variation can consist of two categories
each of which is determined by one allele at a locus. This is the way that simple
Mendelian traits arise: examples range from eye colour to traits such as some forms of
idiopathic familial short stature, and diseases such as sickle cell anemia. The mode of
gene action is recessive if two copies of the alternate allele are needed to produce the
phenotype; this is often the case for syndromes originating from mutations which produce
a non-functional protein. Dominance follows if only one copy of the mutation is
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sufficient for the phenotype. For instance, susceptibility to a disease is often conferred by
the presence of a susceptibility allele, i.e. the allele producing protein with an altered
function, regardless of the number of copies of that allele present in a cell. For both
dominant and recessive characters, the heterozygote is indistinguishable from one of the
homozygotes. In contrast to this, when the heterozygote is intermediate between the two
homozygotes, as often is the case for quantitative traits, the joint effect of the individual
alleles may be additive (the heterozygote phenotype being the sum of individual allele
effects), multiplicative (product of individual allele effects), or it may not follow any easy
mathematical formulation. Only rarely is the heterozygote phenotype outside the range of
the homozygous phenotypes.
When there is no one-to-one correlation between phenotype and genotype, an
additional set of concepts is necessary: Penetrance is the probability of a disease given a
genotype. This can be interpreted as the lifetime risk for the disease in individuals with a
certain genotype at the pre-specified locus. Low penetrance implies that the genetic
predisposition conferred by the genotype is not sufficient to trigger the disease onset. A
phenocopy is an individual expressing the trait, but who does not possess the
susceptibility genotype in question (Figure 6). The oligogenic disease model is
appropriate for a disease where one or a few major genes plus environmental factor(s)
contribute the disease. The polygenic model points the action of several, often
indistinguishable, genes, as well as environmental factors. The environmental factors may
be chemical, physical, infectious, or nutritional. When there is more than one allele at a
locus, or more than one locus affecting the disease, genetic heterogeneity is implied: the
former situation is called allelic heterogeneity, the latter locus heterogeneity.
Figure 6. Schematic diagram of relationships of concepts describing multifactorial
traits. Penetrance can be interpreted as the proportion of genotype carriers who get
affected during their lifetime.
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Complex diseases
Complex diseases are inherited according to an oligogenic or polygenic model: typically,
no clear inheritance pattern is seen, but the disease shows a consistent familial
aggregation. The clustering in families is described by the recurrence risk. If we denote
the probability of the disease in population by K, and the probability for r-degree relative
of an affected proband to be also affected by Kr, then the recurrence risk is
K
Kr
r =λ .
Empirical studies on locus specific recurrence risk (Rotter and Landaw 1984), ie the
genetic contribution of a specific single locus to the total recurrence risk, have shown that
it is quite common that there is one locus with a large effect (major gene) and several
others with weak effects (minor genes). The familial recurrence risks have also been used
for estimation of the number of genes affecting a trait (Koivisto and Mannila 2001), but
only models with rather low numbers of genes can yet be distinguished.
It has been hypothesized that in common diseases, the predisposing alleles would
be common (Lander 1996). The rationale behind this ”common disease, common variant”
hypothesis is that the high disease prevalence itself necessitates that the susceptibility
alleles are common, in which case they also need to be quite old. With common alleles, it
should be possible to test for association with a list of population-based SNPs and to
identify disease-susceptibility mutations in that way (Risch and Merikangas 1996).
Contradictory ideas have been presented by Pritchard (2001), who claims that it is more
probable that there are a large number of different susceptibility alleles with quite high
total frequencies. This is based on an evolutionary model for complex disease loci
incorporating mutation, genetic drift, and weak purifying selection of susceptibility
alleles.
Genotype-phenotype correlation
In essence, the probability of finding a disease gene in genetic marker data is crucially
dependent on the correlation between the markers and the phenotype. This, in turn, is
naturally dependent on the strength of effect of the disease locus on the phenotype, and
the genetic distance between the disease locus and the flanking markers, i.e. the amount
of linkage disequilibrium (Figure 7). In association analysis, the frequency distribution of
marker alleles in affected individuals is compared to frequency distribution in unaffected
individuals. Markers with maximum difference from the distribution assuming the null
hypothesis (which is complete independence between disease status and the markers in
the specified genetic area) are used to infer the possible location of a susceptibility gene.
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Figure 7. Correlations between observed phenotype, observed marker data and the
unknown disease locus. Only the correlation between phenotype and markers can be
detected directly (modified from a lecture by J Terwilliger).
2.5 Gene mapping methods
The statistical methods of disease gene mapping using genetic marker data are
traditionally divided into two categories: those utilizing linkage in the pedigree data, and
those which rely on population association between the phenotype and the markers.
Ultimately, the two approaches just take advantage of the opposite ends of the spectrum
of genetic phenomena. In linkage analysis, one searches for genetic areas which are
shared between related affected individuals. The closer the relatedness, the longer are
these areas and the easier they are to pinpoint. Association analysis works on the
assumption that the affected individuals are related but only distantly; they share the same
disease mutation as well as a short haplotype around it. The longer the time which has
passed since the original ancestral mutation, the shorter is the shared segment. This gives
an opportunity to very accurate localization. Essentially, both methods search for an area
shared IBD as a consequence of inheritance in pedigree, the difference being in the size
of the pedigree (Figure 8).
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Figure 8. Association vs. linkage. The disease mutation has originated in a common
ancestor, and has, through random drift, spread in the population. An association of
conserved haplotype around the disease mutation may still be observed in the
present generation, given a suitable map density and high enough penetrance, as
association analysis seeks for alleles shared in common between the affected
individuals. The gene could also be mapped through linkage, in which the co-
segregation of the phenotype with genetic markers is tracked in pedigrees, without
paying attention to the identity of the allele.
2.5.1 Linkage methods
In linkage analysis, co-segregation of known marker loci with disease status is searched
for in pedigrees which include several affected and healthy individuals. Co-segregation
implies that the susceptibility allele of the unknown disease locus is inherited
concurrently with certain marker allele(s) more often than could be seen if the two were
unlinked. In practice, pedigrees with several affected family members are obtained and
genotyped for a set of markers, either covering the whole genome, or a pre-specified
chromosomal area. There are several approaches to the actual statistical analysis, where
the division to parametric and non-parametric methods is the most fundamental.
28
Parametric linkage analysis
In the simplest case, a single major locus is assumed to affect the trait in question. The
probability of the trait value in individual i is given by the penetrance Pen(Xi | Gi), where
Xi is the phenotype of i and Gi the disease locus genotype of individual i. As an example,
for a dichotomous trait, denoted by D, which is conferred by a single locus with two
alleles, the penetrances could be defined as PenAA=P(D | G=AA), PenAa=P(D | G=Aa),
and Penaa=P(D | G=aa). Let the ith person have phenotype Xi and possible genotype Gi.
Conditioning on the genotypes of each of the n people in a pedigree yields Ott’s
representation of the likelihood
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in the first representation the product of the phenotype in an individual given the
genotype, and the probabilities of the corresponding genotype, are summed over all
genotypes. This expands into the latter form, where the product of all penetrance
probabilities over all individuals, the product of prior probabilities of the j founder
genotypes in the pedigree (those individuals who do not have known parents), and
product of all transmission probabilities in triplets consisting of an offspring m and the
parents k,l, are summed over all genotypes.
The overall likelihood of a data set consisting of several (independent) pedigrees
is the product of pedigree-wise likelihoods. The inheritance model, i.e. the penetrances of
the disease, are given (or guessed if not known) in advance. In reality, the disease locus
genotypes are not known but a hypothetical disease locus is put in the vicinity of a known
marker locus and, given the co-segregation pattern of the trait and the marker genotypes
in the pedigree, the recombination fraction between the hypothetical disease locus and
marker locus is estimated. The procedure is repeated for each marker location through the
genome, the calculation of the value of the likelihood along with estimation of the most
probable value of the recombination fraction. The likelihood is then compared to a
likelihood assuming recombination fraction of 50% that is to the null hypothesis of “no
linkage”. The most commonly used way of assessing the strength of linkage is by
logarithmic odds of the ratio of the two likelihoods (LOD score): 


= )5.0(
)(log)( 10 L
LZ θθ
The term parametric linkage analysis is used to signify that the penetrances and allele
frequencies of the disease locus, as well as allele frequencies of marker loci, are required
in advance.
Non-parametric linkage methods (Affected relative pair methods)
The class of so called non-parametric linkage methods includes methods in which the
sharing of genetic areas between affected individuals in a pedigree is compared to the
expected sharing given the degree of relatedness between the individuals. This type of
analysis is also called affecteds-only method of linkage analysis. As a special case of the
more general affected relative pair method, the affected sib-pair (ASP) method relies on
the intuitive idea that in diseases with a distinct genetic component, siblings affected by
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the same condition probably share susceptibility alleles transmitted through their parents.
The expected sharing in a locus with no effect on a trait is ¼ for 2 alleles, ½ for one, and
¼ for 0 alleles in common between full siblings. The sharing, Z, is estimated in each
markers locus, and compared to the probabilities under the null hypothesis. The number
of alleles shared IBD at a marker locus provides an estimator for the number of IBD
alleles at the trait locus. The observed and the expected sharing can be compared with a
simple χ2-test, but several more refined approaches have been developed (see Davis and
Weeks 1997). New methods test the sharing in the proposed disease locus directly by
utilizing multipoint haplotypes. Sharing in the disease locus can be shown to be
Z0=0.25/λs, Z1=0.5∗λ0 /λs, Z2=1-Z0-Z1, where λs is the sib recurrence risk and λ0 the risk
in population. When the assumed locus has no effect on disease susceptibility, λ0 = λs = 1
and Z=(0.25,0.5,0.25). The LOD score is maximized over Z to provide a test of linkage.
These methods have been implemented in ASPEX (by D Hinds and N Risch,
http://bioweb.pasteur.fr/docs/aspex/usage.html), MAPMAKER/SIBS (Kruglyak and
Lander 1995), and GENEHUNTER (Kruglyak et al 1996).
The affected sib pair methods are non-parametric in the sense that nothing explicit
is assumed about the inheritance model of the disease. The power of the methods is best
for recessive, fully penetrant traits. In extensions of the method, quantitative phenotypes,
as well as relative pairs (other than sibs), have been incorporated.
In addition to the methods mentioned, several other approaches have been applied
for linkage analyses, such as Bayesian inference (Heath 1997, Uimari and Sillanpää
2001) and variance component methods (Almasy and Blangero 1998).
Statistical power of linkage methods
The statistical power of the parametric linkage analysis, ie the probability of rejecting the
null hypothesis of “no linkage” along locations in the chromosome when the null
hypothesis is false, depends on the marker map density, marker information content,
number and size of the pedigrees included, the strength of the effect of the disease locus
on the trait being studied, and the validity of the given disease model. To be able to
observe co-segregation of a disease and a marker locus in a pedigree, it is necessary that
the individuals are heterozygous for the marker loci; the probability of heterozygosity for
a marker depends on the marker information content. If a marker locus and disease locus
are located far apart, the probability of recombination is high (near 50%) and no linkage
can be detected. In practice, a map density of 10-20 cM is sufficient to avoid too high
recombination rates. Low penetrance complicates the linkage analysis: even though a
person carries a susceptibility allele, he or she may be unaffected, and thus gives
ambiguous information of linkage of the marker locus to the disease status. Despite the
shortcomings of the parametric methods, they have proven to be very effective in finding
disease gene loci in single-gene disorders. Also, they are clearly more powerful than the
non-parametric methods when there is a good preconception of the actual disease model.
Compared to parametric linkage, non-parametric analysis is less powerful if a
good approximation of the disease model for a trait is known. If a grossly incorrect
disease model is used, the probability of finding the genes can be very low. For complex
diseases, the underlying mechanisms are not known, and thus use of non-parametric
methods may be warranted. For example, genome scans carried out for the major
complex diseases, such as Type 1 diabetes, have been done on sib-pairs.
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The results obtained in the study of complex traits thus far show great variability.
Whereas several susceptibility genes have already been identified, for instance, for
obesity, there are still only a few confirmed susceptibility loci for some other diseases,
despite great efforts put to the mapping of the complex traits. The most probable reason is
that there are several genes affecting disease susceptibility with very low locus specific
risks, of the order of λs≈1.5. These are very difficult to identify: power analyses show that
even thousands of sib-pairs or core families would be needed to identify genes with these
effect sizes (Hauser et al 1996). In real studies, the typical numbers of sib-pairs collected
have been only a few hundred, resulting in the situation where the actual genes found
have varied widely. It is rare that the same loci are found in replicate studies. For a
polygenic disease with several weak gene effects, it is much more difficult to report a
specific finding than just to find some locus (Suarez et al 1994). One way of increasing
the statistical power is to pool the data over several populations, or to do a meta-analysis
and combine the results across several independent studies (Gu et al 2001).
2.5.2 Association analysis and LD mapping
Using linkage information is preferred when no priors exist for the potential location of
the disease susceptibility genes, and genome-wide scan is warranted. On the other hand,
when (1) prior candidate genes exist, or (2) initial linkage to a genetic region has been
observed, association (or LD) methods are utilized. In a candidate gene approach (1),
known polymorphisms in the candidate area are genotyped, and their association to the
trait measured with standard association analysis methods. If, on the other hand, there is
initial linkage to the trait (2), the goal is to fine-map the region, and a dense set of genetic
markers ranging through the area is chosen, genotyped, and evaluated for linkage
disequilibrium to a true disease gene. Both approaches rely on the assumption that at least
a small part of the disease mutations originate from the same ancestral mutation, so that
there will be a strong enough association (or LD) to the trait in the patients. Thus, they
are considered more suitable for an isolated population setting than large, old and mixed
populations. The basic difference of the approaches is that (1) association analysis is
direct testing of association between the phenotype and markers, irrespectively of the
exact location of the disease mutation, whereas (2) in LD mapping a statistical model of
decay of LD is exploited to actually estimate the location of the disease mutation between
the marker locations, based on strength of correlation of phenotype and markers.
The original simple statistics used for measuring the allelic association, such as D,
∆, and the standard χ2-test, were developed for considering simple marker-marker or
marker-disease -association, where the marker is bi-allelic. All these statistics are
interrelated through simple mathematical derivations. In practice, there are differences in
their sensitivity to, for instance, the population allele frequencies. They have been
compared by, for example, Devlin and Risch (1995), and Guo (1997). The major
drawback in using these marker-wise measures of association is that the values of the
statistics vary greatly, even when pairs of loci are in the same genetic area and at very
similar distances from each other. Lately, association and LD methods have been in the
focus of methodological interest and improvement, as they are believed to offer new,
unforeseen possibilities for genetic analyses, for example, in high-density SNP studies
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(Risch & Merikangas 1996). It is expected that this kind of high-density data will enable
researchers to directly measure the association between candidate genes and the
phenotypes being studied.
Newer approaches are based on likelihood-based modelling of LD around a
disease susceptibility gene (Terwilliger 1995, Devlin et al 1996, Lazzeroni 1998, McPeek
and Strahs 1999, Service et al 1999). Genomic regions, rather than alleles, that are shared
among affected individuals, are searched for. The statistical models are based on more or
less simplified assumptions of the decay of LD. Regardless of these simplifications these
methods have been shown to be more powerful than the traditional methods. Some of the
models are robust to high levels of etiologic heterogeneity (McPeek and Strahs 1999,
Service et al 1999). Some new approaches use Bayesian modelling with MCMC, for
instance, Rannala and Reeve (2001). Their method uses a prior probability of the location
of the disease mutation that is based on information given by human genome sequence
(HGS) information. The prior is updated by estimates of LD at a set of linked markers in
the region, to produce the posterior density of the location of the mutation. Most of the
approaches have been developed for analysing small areas of the genome with rather low
numbers of markers, and are thus best suited for fine mapping purposes. Furthermore,
many are highly computationally intensive, which prevents their use with larger data sets.
Some likelihood-based approaches are based on assumptions which do not hold in real
data sets, and the effects of the violations of assumptions are not known. Missing and
erroneous data, inherent in real data sets, may also have unforeseeable effects on the
power of association methods and on the false positive rates.
It is quite clear that for complex diseases the association methods still have to be
developed so as to be able to detect realistic weak gene effects, and possible interactions
between genes or genes and environment. For instance, if a disease gene contains several
susceptibility alleles at many different sites with low frequencies, the power of current
statistical tests of association will be greatly reduced (Slager et al 2000). One of the major
complications for association methods is thought to be possible population stratification,
which may produce false positive findings when not correctly taken care of in the
analysis. One solution that has been proposed is to use family-based controls, ie so-called
pseudo-controls, but also more systematic methods that directly account for stratification
(and estimate its magnitude in the data) have been presented (Pritchard and Rosenberg
1999, Satten et al 2001).
Lately, there has been increasing interest in integrating the association methods
with the linkage approach; in a way this has been contemplated in the TDT test (Spielman
et al 1993) and its derivatives. These approaches are based on simultaneous consideration
of population association, which is seen in the sample of independent trios (father, mother
and the affected offspring), and the observed transmission of the associating haplotypes
from parents to affected offspring. Such an approach has been presented by for example
Göring and Terwilliger (2000).
In addition, quantitative trait mapping utilising association (or LD) has been a
focus of intensive study: for example, TDT tests have been extended to analyse
quantitative traits (Allison 1997). TDT by variance component approaches in quantitative
trait association analysis has been presented by Abecasis et al 2000), whose QTDT
method also includes test statistics by Fulker et al (1999), Allison (1997), and Rabinowitz
(1997). In contrast to family-based tests, an approach using population samples consisting
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of unrelated individuals has recently been published by Zhang and Zhao (2001). Their
quantitative similarity-based association test measures the association between a
candidate marker and a quantitative trait, using unlinked markers for simultaneous
estimation of population stratification. As most of the populations are more or less mixed,
several methodological approaches to study admixed populations have been presented
recently. Strategies for disease gene mapping specially exploiting the admixture effect
have also been developed (admixture mapping, McKeigue 1997, 2000).
3. Type 1 diabetes
Diabetes has, as a disease, been known for at least 2,000 years; there are notes of patients
with symptoms like sweet odour of urine, made by Roman doctors a few centuries BC.
There was no cure to the disease until 1920’s, when insulin replacement therapy was
invented. Before this, the insulin-dependent type of this disease was invariably lethal, the
patient dying in a matter of months or at the most couple of years after disease onset.
Today, the distinction between types 1 and 2 is made on the basis of disease process: type
1 is conferred by immune-mediated destruction of β cells of pancreas and consecutive
lack of insulin production. Type 1 diabetes accounts for about 10% of all diabetes. In
addition to types 1 and 2, there are some other types of diabetes (Table 4).
The detailed disease pathogenesis is unknown, though the clinical symptoms in
Type 1 are the result of nearly total autoimmune destruction of beta cells. The
autoimmune process itself is presumed to start years before the clinical symptoms appear,
even in the foetal period, which has made it difficult to find the factors that trigger the
process. The disease also occurs, both naturally and induced, in other animal species,
such as dogs, rats and mice. These animal models of the disease have been used
intensively in the study of aetiological process, especially for finding the actual molecular
triggers, which begin the autoimmune process.
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Table 4. Types of diabetes. In addition to those listed, there are rare forms with
varying aetiologies (genetic syndromes, surgery, drugs, malnutrition, infections,
other illnesses). Sources:
http://www.niddk.nih.gov/health/diabetes/pubs/dmstats/dmstats.htm#four,
http://www.childrenwithdiabetes.com/dictionary/
Type Insulin
production
Therapy Prevalence Age at onset Genetics
Type 1 diabetes None or very
little
Insulin
replacement
therapy, diet,
exercise
0.4% of
total
population
Most frequently
in children and
adolescents, but
also in adults
HLA, INS,
several
minor genes
Type 2 diabetes Insensitivity to
the action of
insulin, but also
insulin
Deficiency
Diet, oral
medication,
exercise
Depends on
population;
usually
90-95% of
all diabetes
is Type 2
Primarily in
adults, also in
young
Several loci
known
Gestational
diabetes
Insufficient Appr. 95% of
cases back to
normal when
pregnancy ends
2-5% of all
pregnancies
Pregnant women Not known;
same risk
factors as in
Type 2?
MODY
(Maturity-Onset
Diabetes of the
Young)
Insufficient Weight
reduction, oral
hypoglycaemic
medications
Very rare Children and
adolescents
Mendelian
one-gene
form of
diabetes
3.1 Epidemiology of Type 1 diabetes
Epidemiological studies clearly show that Finland has the highest incidence of Type 1
diabetes in the world, with approximately 40/100,000 cases per year in children below 15
years of age. For comparison, the incidence varies from 0.2–40/100,000 per year
elsewhere in the world (Karvonen et al 1993, 1997). The highest incidences are typically
found in Caucasian populations, particularly in northern Europe, the lowest being found
in Asia and South Africa. In Finland, the prevalence of this condition is approximately
0.4% of total population, which makes it the second most common chronic disease of the
childhood (after asthma). Geographical differences between the counties of Finland are
low (Ranta and Penttinen 2000), but on average there seems to be higher incidence in
rural areas than in cities (Rytkönen et al 2001). Age-at-onset varies considerably, from 0-
30 years of age, the peak being in approximately 9 years. The age-at-onset distribution
has gradually shifted downwards, so that nowadays even very young children get the
disease (Karvonen et al 1999, Dahlquist and Mustonen 2000). It is thought that genetic
factors play an even more important part in the disease aetiology of the youngest patients
(see Hodgkinson et al 2000, Komulainen et al 1999, Valdes et al 1999). In addition to
these characteristics, there are well-known seasonal patterns in diabetes incidence, with a
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lowered incidence during summer in the northern hemisphere (Karvonen et al 1998). An
intriguing aspect is that the probability of acquiring Type 1 diabetes is different if
transmitted through affected father (7%) vs. affected mother (3.5%, Warram et al 1984,
The Eurodiab ACE Study Group 1998). The reason for this difference is not known.
Though the diagnosis of Type 1 diabetes is inevitably much clearer than that of e.g.
mental disorders, the overall criteria of diagnosis had not been agreed upon until the past
decade. For that reason, many national registries including information from the decades
preceding 1980s cannot be interpreted so straightforwardly. Misclassifications of types of
diabetes are likely to have happened relatively frequently. Even today, in developing
countries, where the burden of infectious diseases is the major issue of concern of the health
care system, it is very likely that diabetes is underreported and thus no reliable statistics are
available for a truly global evaluation of the disease epidemiology. For these reasons, the
wide geographical variation in the incidence of type 1 diabetes was first shown in the late
1970s. During the 1960s to the early 1980s, data on incidence of Type 1 diabetes were
only available for a few populations, mostly from regions with a high or intermediate risk
of Type 1 diabetes. The lack of standardized data made it difficult to determine the true
magnitude of the worldwide variation in incidence or time trends (LaPorte et al 1985).
Therefore, international research collaborations were started in 1980s to collect aggregate
data on the incidence of Type 1 diabetes, The Diabetes Epidemiology Research International
Group, DERI (Rewers et al 1988), World Health Organization Project of Childhood
Diabetes (DIAbetes MONDiale) in 1990 (WHO DIAMOND Project Group on Epidemics
(1992), and the collaborative research project EURODIAB ACE (Green et al 1992a). The
standardized procedures agreed upon for the collection of the incidence data now permit a
comparative assessment of temporal trends among several populations.
As a part of this thesis (Publication I), the trends in the incidence of Type 1 diabetes
all over the world, based on a systematic literature review, were analyzed. Statistical
analysis of the data was performed in order to find out whether the trend is truly global.
Another objective was to quantitatively evaluate the extent to which the change in incidence
of Type 1 diabetes differs among populations.
3.2 Genetics of Type 1 diabetes
Susceptibility to Type 1 diabetes is mediated by a combination of a major effect from
HLA region and probably at least ten other susceptibility loci elsewhere in genome
(Risch et al 1993, European consortium for IDDM genome studies 2001). The hypothesis
for a genetic basis is strongly supported by the increased concordance in MZ twins (30-
50%) compared to that in DZ twins (5-27%), and in siblings (4-12%). The recurrence risk
of the disease in siblings, λs, is 15 (Risch 1987). The HLA region is the best known
genetic factor affecting the risk of type 1 diabetes (IDDM1, Singal and Blajchman 1973,
Nerup et al 1974), with approximately 40-50% of sibling recurrence risk mediated by this
region (Risch 1987). The exact role of the HLA in the pathogenesis is still controversial,
but the polymorphisms in HLA class II sub-region containing the tightly linked loci HLA-
DRB1 and HLA-DQB1 seems to be the best predictor of the disease. The class II
molecules present extra-cellular antigens to helper T-cells and are essential in generation
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of immune response against foreign molecules. The DR specificities DR4 and DR3
(when associated with HLA-DQB1 alleles DQB1*0302, also known as DQ8, and
DQB1*02, respectively) have the highest effect on susceptibility. Even as high a
proportion as 95% of diabetic patients carry these alleles (in Caucasians generally, though
in Finland this figure is somewhat lower), whereas in the population the proportion of
carriers is approximately 50%. The strong effect mediated by the HLA can also be
observed in diabetic families with yet unaffected siblings: there is increased prevalence of
diabetes-associated autoantibodies in siblings who are HLA identical to an index case
already suffering from diabetes (Kulmala et al 2000). Other HLA gene loci, besides HLA-
DRB1 and HLA-DQB1, are also known to affect the disease susceptibility: HLA-B locus
has been shown to have an effect (Nejentsev et al 1997, 2000).
The second most important susceptibility locus has been mapped near the insulin
gene (INS, which has been designated IDDM2) on chromosome 11p15 (Bell et al 1984,
Thomson et al 1989), where a VNTR polymorphism on the regulative region of the gene
is associated with differential risk to Type 1 diabetes (Pugliese et al 1997). There are
approximately 20 additional putative loci, showing weak positive signs in candidate gene
analyses and genome screens (Davies et al 1994, Field et al 1994, European Consortium
for IDDM Genome Studies 2001). The estimated contribution of these loci to the overall
genetic risk is small indeed, λs=1.1-2.0. Several genome scans have shown the difficulty
of mapping these small effect loci, for example two simultaneous publications of genome
scans in Nature Genetics in 1998 showed that loci found by one study could not be
identified by the other (Mein et al 1998, Concannon et al 1998). A recent meta-analysis
on linkage data gathered in several populations, consisting of 800 sib pairs altogether, has
finally been able to replicate some of the earlier findings with six of the candidate genes
being confirmed (Cox et al 2001). An independent investigation of Scandinavian patient
material (408 multiplex families) confirmed HLA, INS and IDDM15 (European
Consortium for IDDM Genome Studies 2001). The overall conclusion has been that the
sizes of data sets used for mapping the additional loci have been deficient for the purpose.
Despite the recent advances in disentangling the complex genetic background of
Type 1 diabetes, still some questions remain unanswered. What is the aetiological process
leading to the overt disease? What are the triggers that start the production of auto-
antibodies against the pancreatic Beta cells? What is the precise role of the major
susceptibility gene complex, HLA, in this process? Are the numerous minor susceptibility
loci that affect the disease susceptibility same in different populations, and what are their
effects in the disease pathogenesis? Why is the incidence of the condition increasing, and
why is the inheritance of the disease characterized by such peculiar patterns, as described
in the previous section?
From the perspective of statistical methodology, it is evident that there are not
many options left for improvement of linkage methods in order to find small effect loci in
type 1 diabetes, or that linkage methods alone can be used to narrow down the genetic
areas, as the number of recombinations gets too low even in the largest data sets.
Furthermore, it is anticipated that in future genetic studies will mainly be done by
searching for associations with candidate loci or candidate areas. Thus, there is clear
interest in trying new approaches for association analysis. In this thesis, one such
approach, an application of association rules from data mining to find interesting patterns
of haplotypes in genetic marker data, is presented. This work led to a still ongoing project
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designing new methodology with approaches borrowed from computer science. Two of
the papers have been included in this dissertation, the original publication describing the
method, results with simulated data and with real data, and a consecutive paper in which
the method has been extended to quantitative traits.
During 1980s and 1990s some reports had raised the issue of possible preferential
(non-Mendelian) transmission of diabetes-associated alleles from parents to offspring (Jin
et al 1994, Klitz et al 1986, Vadheim et al 1986, Martin-Villa et al 1990, Kockum et al
1994, Eaves et al 1999). This means that some alleles might not be segregating in the
normal, Mendelian 50% probability. The interest in such a phenomenon comes from
observations of patterns of inheritance of Type 1 diabetes: the difference in maternal and
paternal transmission of the disease itself, where the probability of child to have diabetes
is two-fold when the father is affected compared to the mother being affected (Warram et
al 1984, and The Eurodiab ACE Study Group 1998) is yet unexplained. Secondly, the
haplotypes DR3,DQ2 and DR4,DQ8 are common in most populations, despite them
rendering susceptibility to diabetes (and some other autoimmune disorders), which might
be at least partly explained by the proposed unequal probability of transmission. Thirdly,
some ideas have been presented suggesting that the increasing incidence of Type 1
diabetes could be related to a change in the genetic pool of populations. Thus, we wanted
to empirically assess the transmission probabilities of the diabetic alleles in the large
genetic epidemiological data set we had at hand in National Public Health Institute.
We also wanted to find out to what extent possible non-Mendelian transmission
could affect population allele frequencies of the distorting allele. We present a simple
single gene model in order to evaluate the magnitude of the allele frequency change in
time, and by assuming reasonable penetrance probabilities evaluate the effect on time
trend of the incidence of Type 1 diabetes. We fit this model by applying the method of
maximum likelihood, using data of newly diagnosed Finnish Type 1 diabetes cases under
the age of 15, registered between 1965 and 1996.
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4. Aims of the study
The main aims of the present investigation were to develop genetic epidemiological
methodology and to apply it to Type 1 diabetes. The specific aims were
1. To evaluate global incidence trends in Type 1 diabetes
2. To study possible reasons for the increase in incidence, from a genetic point of
view, with a simple population genetic model assuming elevated transmission
probabilities for susceptibility alleles
3. To develop methods for estimating transmission probabilities of susceptibility
alleles in variable age-at-onset disease data, and to apply it to Type 1 diabetes
data
4. To develop new, more sensitive methods for finding complex disease loci by
making use of association: the goal was to develop methods that could take
into account all possible associations, and not to rely on restricting
assumptions. With this aim in mind, data mining algorithms were applied to
the problem of mapping a binary phenotype (affection status) locus using
relatively dense microsatellite or SNP haplotype data. This work resulted a
new method for association analysis, the Haplotype Pattern Mining. Later on,
the HPM was further developed in order to be able to analyze quantitative
phenotypes.
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5. Materials and methods
5.1 Worldwide incidence trend analyses
Literature search
The incidence data for the worldwide trend analysis were collected with a literature
search using MEDLINE, direct examination of reference lists of the articles, and
hand searches of selected journals, and published conference abstracts. The final date
considered was February 28th 1999. More than 160 original publications reporting
time series of the incidence of Type 1 diabetes were found.
Inclusion criteria
The publications were evaluated with strict inclusion criteria to include only those
studies with adequate reliability for meta-analysis. The inclusion criteria were 1) the
study period was 8 years or more 2) the incidence rates were presented for each year
separately 3) the number of cases per year was 5 or more 4) in the papers where the
age standardization had been reported the incidences had been estimated with age-
standardization according to the world population, and, 5) the type 1 diabetes was
diagnosed according to the WHO definition.
Incidence data were obtained either from tables or from figures in the
published articles. Altogether 37 studies from 27 countries met the inclusion criteria
and were included in the analysis (Table 1, Publication I). The period of the studies
ranged from 8 to 32 years, with the average length being 14.9 years. The estimates of
the degree of case-ascertainment were high, ranging from 85 to 100. The studies
included in the analysis were covered the period 1960 to 1996.
Linear regression for trend estimation
Simple linear regression under the assumption of normally distributed errors was used to fit
a temporal trend for each population. Logarithmic transformation of the age-standardized
incidence was explained by the calendar year as independent variable: lnλi(t)=αi+βit, where
λi(t) denote the age standardized incidence predicted at year t for population i, the
intercept αi is different for each population, and βi is the population specific regression
coefficient (the trend), respectively. In this form, the regression coefficient (×100%) can be
interpreted as percentage, which is approximately the average relative increase in incidence
per year. This multiplicative regression model was used, because it fits the data well, and is
commonly used in estimating time trends in incidence.
The overall (global) estimate of the relative annual increase was obtained by using
a pooled, centralized data set: first, for each population, the logarithms of the age
standardized incidence rates and the time points were centered in order to make different
length of studies and incidence levels more comparable. Then, using the method of least
squares, a straight line constrained to cross the origin of the centered coordinate system
was fitted to the pooled data set. The regression coefficient has the same interpretation as
in the population-wise analysis. The analysis was subsequently repeated as weighted
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regression, where residual sum of squares was weighted by the number of cases in
individual studies to give more weight to observations with a higher number of cases.
We also predicted incidences for the year 2010, with both the multiplicative and
additive regression models. The additive regression model was fitted by using the age-
standardized incidence was used as dependent variable without logarithmic
transformation. The curves were simply extrapolated to the year 2010. In essence, the
multiplicative model fits an exponential curve to the incidence, whereas additive model
fits a straight line.
5.2 A population genetic model for incidence
Model
To evaluate the magnitude of effect of a possible non-Mendelian tranmission of
susceptibility allele(s) in a population, given that such exists, a simple population genetic
model was constructed. The model is based on following population genetic principles:
there is random mating in a population (with respect to the susceptibility locus). A single
diabetes-associated allele in one locus is assumed to show transmission distortion. The
allele showing the transmission distortion and conferring increased susceptibility to Type
1 diabetes is denoted by 'A'; other alleles in that locus are simply collapsed to 'a'. τ is
used to denote the probability of inheriting A from a heterozygous Aa parent. If
inheritance is Mendelian, τ = 0.5. For simplicity, penetrances of susceptibility alleles
were assumed to be constant through time. All individuals with a certain genotype and in
some specified age class have the same probability of Type 1 diabetes through the whole
time period.
Let k denote the genotype k = 1,2,3 for genotypes AA, Aa and aa, respectively,
and b the birth cohort. The genetic model was constructed as follows. The genotype
frequencies are in Hardy-Weinberg equilibrium in the first generation. Let qk(t) denote
the genotype frequencies of genotype k (k=1,2,3) in generation t, and let rAt and rat
denote the allele frequency of A and a in generation t, respectively. All mating types,
their frequencies (based on the assumption of random mating), and the genotype
frequencies in the offspring are given in Table 1, Publication II.
Summing over all mating types, the expected new genotype frequencies in the generation
t+1 are then
q1(t+1) = (q1(t))2 + 2q1(t)q2(t)τ + (q2(t))2τ2
q2(t+1) = 2q1(t)q2(t)(1-τ) + 2q1(t)q3(t) + (q2(t))22τ(1-τ) + 2q2(t)q3(t)τ
q3(t+1) = (q2(t))2(1-τ)2 + 2q2(t)q3(t)(1-τ) + (q3(t))2
Thus, the genotype probabilities in the offspring depend only on the transmission
probabilities of the alleles and genotype frequencies of the previous generation. In order
to obtain the genotype frequencies for annual birth cohorts between these generations, a
linear approximation of the equations was used, as we were mainly interested in finding
out the approximate magnitude of the effect, not its exact value.
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The model was used to simulate the allele (and genotype) frequency change in a
population where there is increased transmission of certain alleles. By adding age-group
and genotype specific incidences, the expected population incidence can be obtained.
Parameter estimation
Speculating further with the population model, we wanted to estimate the transmission
probability from the real annual incidence data when assuming that this would be the
only factor changing the incidence through the study period. The transmission was
estimated by fitting the genetic model for the increasing incidence to the data of new
Type 1 diabetes cases in Finland from 1965 to 1996. The penetrances, λjk, were assumed
to be constant in the age groups 0-4.99, 5-9.99, and 10-14.99 years, in order to reduce the
number of parameters to be estimated. Given that Type 1 diabetes is a rare disease and
that the numbers of new cases in each year, age group and genotype class are mutually
independent, the number of incident cases should be Poisson-distributed. The Poisson-
likelihood was expressed as
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where ( )0,),3,2,1,( qkjθ jk τλ == , dij is the number of new cases in year i in the j-years-
old, and µij is the expected number of new cases in a year based on genotype frequencies
and penetrances. The frequency of susceptibility allele was chosen to be 0.2 at the start of
the time period considered (in the 1930s). The initial value of the transmission distortion
τ was set to 0.5, corresponding to no transmission distortion.
The Finnish annual age-specific incidence data
Data on the new cases of Type 1 diabetes in Finland were obtained from two nationwide
sources: new cases between 1965 and 1986 were obtained from the Central Drug Registry
of the Social Insurance Institution, and between 1987 and 1996 from the prospective
childhood Type 1 diabetes registry. In Finland, all children with Type 1 diabetes are
treated in hospital at the time of diagnosis and therefore case ascertainment is virtually
100% complete. Details of the data collection are described elsewhere (Tuomilehto et al
1991, 1992).
5.3 Estimation of transmission probabilities in HLA
In order to evaluate the hypothesis of non-Mendelian transmission in HLA loci in the
Finnish population, the transmission probabilities were estimated from the data that has
been collected for the diabetes study by the Genetic Epidemiological Unit in NPHI,
Finland. As the data has been collected for a study of Type 1 diabetes in the families, it
was not straightforward to estimate transmission probabilities in diabetes-associated loci,
as transmission of alleles in these loci is not independent of the ascertainment event.
Thus, an approach to take this ascertainment effect into consideration had to be made.
The DiMe data
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Estimation of the transmission probabilities of the diabetes susceptibility loci (HLA A, B
and DR) alleles was made using the Childhood diabetes in Finland (DiMe) study
families. The DiMe study is the largest population-based genetic-epidemiological family
study of Type 1 diabetes (Tuomilehto et al 1992). Nationwide, all cases under the age of
15 were identified during the recruitment period from September 1986 to April 1989. The
whole data set consists of 801 participating families with at least one Type 1 diabetic
child. Affected children as well as their parents and siblings were HLA genotyped at A, B
and DR loci using conventional serology. HLA genotyping was done on 757 families.
The details of the study procedure are described in Tuomilehto et al (1992).
Ascertainment correction
In the case of a random sample, the estimation and testing of transmission probabilities
can be done using routine methods (Jin et al 1994). However, our family data was
obtained from a biased sample, i.e. there was at least one affected child per family. This
means that transmission of diabetic allele(s) has almost surely occurred at least once per
family, as 90% of diabetics carry known HLA susceptibility alleles. Correction by simply
leaving out the index child is not a very good option in order to get unbiased estimates of
the transmission rates, as the probability of a family having been included in the data set
depends not only on the index child but, on the other offspring at risk at the time period
of recruitment as well (as these offspring also contribute to the probability the family is
ascertained to the study). Therefore it is crucial to take the method of ascertainment into
account in the estimation of transmission probabilities.
Using these basic assumptions, 1) dates of birth of offspring and genotypes of the
parents are known 2) for sibships in the general population, the transmitted parental
alleles and affection statuses are conditionally mutually independent given the dates of
birth and the genotypes of the parents, 3) independence of different sibships, it can be
deduced that the genotypes of all siblings younger than the index child are always
sampled independently of the events that led to the ascertainment of the family. As a
consequence, there are three possible subsets of children in each sibship: 1) children who
were older than 15 years at the beginning of the recruitment period 2) children who were
eligible to become a proband and older than the index child, or the index child
himself/herself, and 3) children younger than the index child. Genotypes, i.e. the
transmission of alleles from parents to offspring, are independent of the ascertainment in
sets 1 and 3, but not in set 2 through which the ascertainment of the family has taken
place. Children in set 2 who were not diagnosed with Type 1 diabetes during the
recruitment period are less likely to have inherited diabetic genes than a random child of
the same parents. Excluding set 2 from analysis allows one to make unbiased inference
without need to model the probability of the ascertainment event. The mathematical proof
of the above formulation is given in Publication III.
Estimation of transmission probabilities and the statistical tests
First, the single allele transmission probabilities and their variances (as in Jin et al 1994)
were estimated from the data. Tests for allele specific deviation from the expected 50%
transmission were carried out on these estimates, as described in Publication III. A locus
specific (global) test for an overall deviation was also carried out. All tests were done
separately for males and females, to allow for sex-specific effects. The global test for
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Mendelian transmission is based on the number of observed transmissions, nrs, of all
possible alleles r from all parental genotypes r,s, where r ≠ s, and r<s. The sum of
squared standardized normally distributed random variables is approximately χ2–
distributed with A(A-1)/2-A0 degrees of freedom, where A is the number of alleles and A0
the number of genotypes not seen in the data. Finally, we carried out a goodness-of-fit
test, where single allele transmissions are estimated simultaneously and there are less
parameters to be estimated than in the global test. The details of the testing are given in
Publication III.
Only parent-child sets with complete HLA genotypes were eligible for use in the
transmission estimation. In the DiMe data there were altogether 718 siblings in 471
families who were born after the oldest child in a family that was diagnosed with Type 1
diabetes during the enrollment period. The numbers of families, individuals, and
transmissions eligible for the analysis are given in Table 1, Publication III.
5.4 Haplotype Pattern Mining
Extension to traditional association analysis
In association analysis, the strength of association of a trait is measured either a marker or
a haplotype at a time, with either simple association measures or with statistical
modelling of LD designed for the purpose. The methods reviewed in chapter 2.5.2 and in
Publications IV and V offer possibilities for a refined analysis for fine scale mapping, but
often are not suited for larger stretches of the genome or for genetically very
heterogeneous data (or genes with very small effects). Thus, the goal for developing a
new approach for association analysis was to 1) exclude restrictive assumptions typical in
most current methods and 2) to account for all association observed through the whole
area studied in a single analysis.
Haplotype Pattern Mining (HPM) is based on algorithms developed to find
frequent patterns efficiently from large databases (Agrawal et al 1993, Agrawal et al
1996). The method uses haplotypes as input; they can be obtained with Genehunter
(Kruglyak et al 1996) for example. In diseases with a reasonable genetic contribution,
affected individuals are likely to have higher frequencies of associated marker alleles
near the DS gene than control individuals. Combinations of marker alleles, which are
more frequent in disease-associated chromosomes than in control chromosomes, are
searched for in the data, without making any assumptions about the mode of inheritance
of the disease. These combinations, haplotype patterns, are sorted by the strength of their
association to the disease, and the resulting list of haplotype patterns is used in localizing
the DS gene. The method is an algorithm-based extension of traditional association
analysis.
Data mining
Data mining, or “knowledge discovery in databases” (KDD) can be defined as methods
for discovery of useful information from large collections of data. The new information
being searched for may be the detection of unexpected, new associations between
variables in the data, clustering of the objects in the database, etc. These objectives are
achieved by use of intelligent, computationally efficient algorithms, such as association
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rules. Data mining algorithms have been successfully applied to a wide set of fields:
market basket analysis, direct marketing, DNA sequence search, telecommunications
network alarm analysis, to mention a few (http://www.cs.helsinki.fi/~mannila/).
Finding haplotype patterns
We look for haplotype patterns that consist of a set of nearby markers, which are not
necessarily consecutive to each other. Given a marker map M with k markers m1,…,mk, a
haplotype pattern P on M is defined as a vector (p1,…,pk), where each pi is either an allele
of mi or the “don't care” symbol (∗). The haplotype pattern P occurs in a given haplotype
vector (chromosome) H = (h1,…,hk)if pi = hi or pi = ∗ for all i, 1 ≤ i ≤ k. For example,
consider a marker map of 10 markers. The vector P1 = (∗, 2, 5, ∗,3, ∗, ∗, ∗, ∗, ∗), where 1,
2, 3,… are marker alleles, is an example of a haplotype pattern. This pattern occurs, for
instance, in a chromosome with haplotype (4, 2, 5, 1, 3, 2, 6, 4, 5, 3).
Our goal is to search for haplotype patterns that roughly correspond to haplotypes
that are identical by descent in the disease-associated chromosomes. We allow for gaps in
the haplotype patterns since mutations, errors, missing data, and recombinations can
corrupt continuous haplotypes. Marker mutations and errors typically will cause only
very short gaps.
The maximum length of the patterns as well as the maximum number of gaps are
parameters defined by the user. It hardly would make sense to look for patterns of
unrestricted length and complexity, as it is expected that in most cases the data consists of
relatively sparse marker map, with even the longest conserved ancestral sequences
perhaps 10 cM long.
In the basic version, the HPM method is presented in terms of the (signed) χ2 -
measure of marker-disease association. A signed version of the measure is used in order
to discriminate disease association from control association, the positive measure being
obtained when the pattern P is more frequent in cases than in controls, and negative
otherwise. Given a “positive association threshold” x, we say that P is strongly associated
with the disease if χ2 ≥ x. The first part of the HPM method is to output all haplotype
patterns that are strongly associated with the disease status for a given value of the
association threshold x. If pattern parameters are specified - a maximum genetic length, a
maximum number of gaps, or a maximum length for gaps - the task is refined by
requiring that these additional restrictions are also fulfilled. On another hand, given such
a frequency threshold, all patterns exceeding the threshold can be enumerated efficiently
with data mining algorithms (Agrawal et al 1993, 1996).
Gene localization
Haplotype patterns close to the DS locus are likely to have a stronger association to it
than haplotypes further away; consequently the locus is likely to be where the strongest
associations are. We compute the marker frequency f(mi) of marker mi with respect to
M,H,Y,x, where Y denotes the phenotypes, as the number of patterns that contain marker
mi, possibly in a gap. The idea is that each haplotype pattern roughly corresponds to a
continuous chromosomal region, potentially identical by descent, where gaps allow for
corruption of marker data. While markers within the gaps are not used in measuring the
disease association of the pattern, the whole chromosomal region of the pattern is thought
to be relevant.
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The marker frequency gives a score for each marker. On the condition that we
assume a DS gene to be present, e.g., based on linkage analysis, we would predict the
gene to be somewhere close to the markers with largest frequencies. As a point
prediction we could simply give the locus of the most frequent marker. This does not, of
course, imply that we assume the DS locus to really overlap with the marker; we simply
predict at the granularity of marker density. Consequently, the optimal point predictions
of our method are within one half of the inter-marker distance from the true loci.
Permutation tests
The results obtained by considering marker frequencies can be contrasted against the null
hypothesis that “all the chromosomes are drawn from the same distribution”, i.e., that
there is no gene effect in the disease status. Permutation tests can be used for this
purpose. The permutations are carried out by randomly shuffling the status fields of the
chromosomes in a data set, keeping the proportions of affected and control chromosomes
constant, in a fashion similar to Churchill and Doerge (1994). The p-values are obtained
marker-wise, and the DS gene is predicted to be in the vicinity of the marker with the
smallest empirical p-value. Consecutive markers are dependent, and thus a large number
of mutually dependent p-values are produced. This is not a problem, since we do not use
the p-values for hypothesis testing, but only for ranking markers.
Quantitative traits and utilization of covariates
HPM was extended to utilize information from quantitative traits, either as a response
variable or covariates. This has been accomplished simply by measuring the strength of
association with a linear model. The quantitative trait HPM, or QHPM, is carried out as
follows. First, all haplotype patterns that occur at least once were searched. For each
pattern we fit a linear model predicting the chosen phenotype,
Yi = α + β∗Pj + β1∗X1i + β2∗X2i + ... + βn∗Xni
where Pj is the indicator variable for the occurrence of the pattern j in the chromosome
being studied, Xni is the value for nth explanatory variable for individual i, and Yi is the
trait value for that individual. The explanatory variables, or covariates, might be
environmental factors, sex, and age at examination. The model was fitted using functions
in publicly available statistical programming language R (Ihaka and Gentleman 1996).
The significance of a pattern as a covariate was obtained from a t-test comparing the
model to the best fitting model in which the corresponding coefficient is zero. These
nominal significances (p-values) form the basis for the scoring function for markers used
in this approach.
Scoring functions
For each marker in turn, all haplotype patterns that overlap with the marker are
considered. The markers, in which the overlapping haplotype patterns show strong
association to the phenotype are those of the most interest. The distribution of observed
nominal p-values of all haplotype patterns overlapping a marker were compared to p-
values distributed uniformly between 0 and 1. This is because uniform distribution is
expected for mutually independent patterns not associated with the trait. We acknowledge
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that the patterns we observe are not mutually independent, but use the uniform
distribution as an approximation of the expected distribution, under the null hypothesis of
no trait association. As a measure of difference to the observed distribution of p-values
the following heuristic scoring function was used. Let pi be the ith smallest p-value of the
n observed p-values for a given marker, and qi the corresponding expectation (i/(n+1) if n
p-values were randomly picked from the uniform distribution. The score was defined as
the mean of the distances (pi -qi) log (pi/qi) (partial Kullback-Leibler distances). This
measure yields larger distances when the observed distribution is skewed towards lower
p-values. The disease gene is predicted to be in the neighbourhood of the marker with the
largest distance measure.
In addition to the modified K-L distance, two other measures for scoring function
were tested, namely the Kolmogorov-Smirnov goodness-of-fit test (comparing the
observed and expected distributions of the p-values) and adjusted R2 of the linear
regression model (the rationale behind being that R2 should reach higher value when a
new explanatory variable is added to the model).
Simulated data with binary affection status
The performance of HPM and QHPM were evaluated with simulated data sets. The data
were produced by the Populus simulator package (V. Ollikainen 2002, dissertation), to
correspond to a small, isolated founder subpopulation. The population grows from the
initial size of 300 to approximately 100,000 individuals over 500 years. Each individual
was assigned a pair of homologous chromosomes. The length of chromosome was 100
cM for both sexes. Crossing-over is allowed to take place with equal probability along the
chromosome, and without any chiasmatic interference. The density of microsatellites was
1 per cM, and that of SNPs 3 per cM of chromosome. The PIC (polymorphism
information content) of the simulated microsatellites was set to 0.7, and that of SNPs
0.375 (the two alleles being equifrequent).
The disease allele was assumed to be dominant, so that each individual with at
least one susceptibility allele has the same probability of disease. A high phenocopy rate
was used (individuals with no susceptibility alleles are assigned as being affected): the
proportion of chromosomes actually carrying the susceptibility mutation was 2.5-10%,
which correspond to relative risks of first-degree relatives of λ=1.2-4.1. The sample sizes,
which were ascertained from the simulated population replicates, were small, 100
affected individuals with 100 pseudocontrols, in order to keep the testing situation as
realistic as possible. The effects of erroneous data were tested by introducing random
errors in 0-10% of the data, and the effect of missing data by removing 0-20% of alleles
randomly. For simulated SNPs, missing data were simulated by randomly removing
12.5% of the alleles. This was done in order to mimic the effect of haplotyping
ambiguities with SNP markers, expected to occur whenever a family trio, both parents
and the only offspring, are heterozygous in a given locus.
Simulated quantitative trait data
The quantitative trait data was simulated in a corresponding manner than the
dichotomous trait data, with an isolated population growing from 100 founder individuals
to 100,000 in 20 generations. The genetic length of the simulated chromosomes was 100
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cM for both males and females. Within this region, the disease locus was randomly
selected, and 6 founder mutations were randomly assigned to the initial population, all of
which were then associated to a different founder haplotype. No chiasmatic interference
was modelled. The simulated microsatellite markers had 4 alleles with frequencies of 0.4,
0.2, 0.2, and 0.2 in the founder population. The markers were spaced 1 cM apart. We
computed the liabilities for each individual using two alternative models:
1211 2 CxxxxM reeg ++++= , (difficult model) and
2212 5 CxxxxM reeg ++++= , (easy model) where
xg is an indicator variable for the presence of at least one of the disease-predisposing
mutations, so the disease alleles are dominant with reduced penetrances. Variables xe1 and
xe2 are environmental components and xr an unobserved random component, all of which
follow a standard normal distribution. Constants C1 and C2 represent the baseline
liability, and they are adjusted in an extra pre-sampling phase to make the prevalence of
the disease as close to the target value of 5 % as possible. When the liability of an
individual has been computed, the disease statuses are defined in the simulation in the
following manner: an individual’s probability of being affected is obtained from formula
iMp
p
=
−1
log ,
where i=1 for the difficult and i=2 for the easy model.
Five quantitative traits, Q1 to Q5, were simulated per each model. The value for each trait
Qj was computed from formula
rxxjxQ eegj +++= 21 ,
where xg, xe1, and xe2 are the genetic and environmental liability components described
above and are the same for all traits, and r is a random value between zero and unity.
To make the simulations more realistic, a population model with substructure was
used. The substructuring might have a major impact on the amount and patterns of LD
observed. Thus, we chose to divide the total population into 4 smaller subsections. A
moderate amount of migration between neighboring subpopulations was assumed: the
probability that an individual born in a subpopulation migrates to another is 4%. Within
each subpopulation, spouses are selected randomly.
The sampling from the simulated population was done on the basis the affection
status: 200 independent trios with an affected offspring were randomly sampled. For the
analysis of quantitative traits no further sampling based on values of quantitative traits
was done. This ascertainment scheme closely resembles real studies in the sense that data
is often collected through an affected proband, and there are correlated quantitative traits
which could also be genetically mapped.
HLA data
We applied our method to a real data set, consisting of sib-pair families with type 1
diabetes from the UK (Bain et al 1990), which were genotyped for 25 polymorphic
microsatellite markers. These markers covered a 14 Mb region including the entire HLA
complex. The HLA-DQB1 and DRB1 loci are the primary constituents for Type 1
diabetes susceptibility mapped to this region. This data set was originally obtained in
order to investigate the accuracy by which this locus could be mapped with currently
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available statistical methods. To test HPM in a setting similar in sample size to the
simulated cases, only 200 out of the original 385 affected sib-pair families were used,
with only one of the affected offspring selected randomly in each family. Control
chromosomes were generated by including only the non-transmitted alleles or haplotypes.
HPM was applied to this data set using the same parameters as described for the analysis
of the simulated microsatellite data.
INS data
Following Publication IV, several experiments were carried out with both different kinds
of simulated data sets, as well as with real data. These included an as yet unpublished
analysis of INS gene data. This data set contains 435 families from the UK, US and
Denmark, each with two offspring diagnosed with Type 1 diabetes, and their parents
(Bain et al 1992). The genetic region studied was around the IDDM2 locus, i.e. the INS
gene on human chromosome 11p15.5. Eight markers had been typed, 6 SNPs, one
microsatellite, and VNTR locus. The microsatellite locus contained 6 alleles, whereas the
VNTR locus contained 81 alleles, which can be divided into two major classes on the
basis of the allele lengths. The allele classes are called I and III, where only class I alleles
are associated with increased risk of Type 1 diabetes. As the markers are densely spaced,
the shortest distances being only 300 bp, it was expected that there would be very strong
LD between them. The SNP alleles were denoted with 1 and 2, 1 for previously known
positively associated alleles and 2 for non-associated alleles, respectively, in the analyses
reported here.
First, only one affected child per a family was chosen, so as to avoid problems of
having familially correlated cases and controls in the data set for HPM. The data set was
divided into two parts: in the first one the first child was always chosen, together with
non-transmitted parental chromosomes as controls, and in the second set the younger
child was used. The data was haplotyped using Genehunter2. For technical reasons,
families in which there was missing information, or the offpring chromosomes had
undergone recombinations, were left out of the final datasets. This resulted in 382 family
trios in the first data set and 372 in the second.VNTR alleles were either used as such in
the haplotype search, or the VNTR class was used.
HPM pattern search parameters
For evaluation of the basic HPM (in Publication IV), the following parameter values were
chosen. The maximum length of haplotype patterns was restricted to seven consecutive
markers, which corresponds to segments of 6-8 cM. This is close to the average length of
shared haplotypes in a population of approximately 500 years of age. At most two gaps
were allowed per haplotype, and their lengths were limited to one marker. With these
parameter values, localization time for one simulated data set on a 400 MHz Pentium PC
was around one minute. After some experimenting, the association threshold for the
signed χ2 measure was set to x = 9. To ensure that the selection of these particular values
is not critical for the method and to assess the robustness of HPM in this respect, we also
experimented using patterns of unlimited length, with longer gaps, and without gaps. For
simulated SNP analysis, the pattern search parameters were modified slightly, to account
for the higher density of markers: the maximum length of a haplotype pattern was 21
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markers (approximately 7 cM). The maximum number of gaps was two and the
maximum length of a gap was one marker.
QHPM parameters
The QHPM analyses were mostly made using one set of parameter values: the maximum
length of the haplotype patterns to search for was set to 7 markers, and the maximum
number of gaps per pattern to 1, with the maximum gap length being 1 marker. The
minimum number of occurrences of a pattern was 10 (frequency limit), to exclude
patterns for which significant association could not be obtained. Experiments with other
parameter settings have been described in Publication IV, in which it was shown that the
method is extremely robust against different choices of parameters.
49
6. Results and discussion
6.1 Trends in incidence of Type 1 diabetes
European populations
In general the incidence of Type 1 diabetes was higher in European populations than among
other non-Europeans (Figures 1 and 2, Publication I). This probably reflects the fact that
Caucasoids tend to have higher level of incidence in general than Mongoloids and Africans
do, though there are geographical differences in incidence depending on the admixture
between racial groups and possible environmental exposures (Karvonen et al 1993). The
level of increase seemed to be similar in some geographically adjacent populations: For
example in the Northern European countries; Finland, Sweden and Norway where the
incidence of Type 1 diabetes has been high for a long time, the increase was 1-3% per year.
Adjacent countries around the Baltic Sea, Estonia, Latvia, Lithuania and Poland with an
intermediate or low incidence (4-10/100,000/year) showed an upward course but not a
statistically significant trend in incidence. The increase in incidence in Eastern Europe
varied from 2.1% per year in East Bulgaria to 8.5% per year in Hungary. The four
populations from UK had the mean incidences from 14.3 to 21.6 and increase in incidence
ranged between 1.9 % and 3.7 % except for Leicestershire, where mean incidence was 7.8
with increase of 9.5%. The Leicestershire data, however, were considerably older (from
1965 to 1981) than from other UK study populations. Speculating on the observed changes
in incidence, there seems to exist a tendency for incidence to be increasing in the countries
with “western” life-style and high living standard, and the former socialist nations, which
are in a process of change, with the possible exception of Baltic countries.
Non-European populations
The data for other than European populations (and especially non-Caucasians) was
sparse: from Asia, data included Japan and China. From Africa we had Algeria and
Libya, from South America only Mestizos in Peru, and we also had Polynesians in
Hawaii. There was marked increase in incidence for all these countries. The data from the
US and New Zealand were contradictory in the sense that there was marked, statistically
significant increase in incidence in two of the populations included, while in the others
the increase seems only modest, and do not reach statistical significance. Naturally,
differences in sample sizes from different populations might have an effect on these
results.
Global trends
The global annual increase was 3.0% (95% CI 2.59;3.33, p=0.0001) during 1960 to 1996,
demonstrating a highly significant increasing trend. When the annual incidence rates were
weighted with the number of cases in each individual study, the increase in incidence was
2.5% (95% CI 2.32;2.66; p=0.0001). The estimated population-wise regression lines
illustrate well the increasing trends (Figures 1 and 2, Publication I).
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Conclusions
Generally, a lower base-line level of Type 1 diabetes incidence was associated with an on
average higher annual increase in incidence (Figure 3, Publication I). The association
between the level of incidence and increase in incidence was assessed by calculating the
correlation coefficient between the logarithms of incidences in 1983 predicted by the
model and the incidence increases estimated by the multiplicative model, where the year
1983 was chosen because almost all studies covered it.
Predictions based on the linear model showed that Finland still would have the
highest incidence in the world (50/100,000/year) in year 2010. However, when this
prediction is compared to the actual incidence estimates from years 1997-2000, which have
been 44.6/100,000/year, 50.0, 49.1, and 45.9, respectively (A Reunanen, personal
communication), the prediction seems to be inadequate, as the actual increase rate is even
more striking. According to the predictions, the next highest incidences will be in Norway,
Prince Edward Island (Canada), Western Australia, Scotland (UK), Oxford (UK), and
Sweden. Despite the large relative increases in the incidence observed in China and Peru,
the absolute incidence rates in these countries would still remain low, less than
2/100,000/year. Based on these predictions, the incidence in Japan will be lower than
5/100,000/year and in Poland, Latvia and Lithuania the incidence will be under
10/100,000/year.
In addition to the findings that were made in this study, the literature review
revealed other populations where an increase in the incidence of Type 1 diabetes had
been reported (these studies were not adequate for the meta-analysis according to the
criteria we used, but otherwise valid). These were Croatia, Denmark, Kuwait, the
Netherlands, Russia, and Switzerland (Schoenle et al 1994, Ruwaard et al 1996, Bingley
and Gale 1989, Green et al 1992b, Jaksic et al 1996, Choubnikova et al 1996, Shaltout et
al 1995).
6.2 Effects of segregation distortion of susceptibility alleles on
the incidence
Expectations based on the model
The simple population genetic model can be used to assess the extent to which the allele
and genotype frequencies may increase in the course of a few generations with varying
values of τ: Three different values were illustrated in Figure 1 a-b, Publication II.
Obviously, in the situation where the susceptibility allele is dominant with high
penetrance and high initial allele frequency, the incidence is high. The relative change in
incidence is most prominent in case there is a large difference in the relative genotype
specific penetrances, even if the change in allele frequency is small. It is obvious from
these considerations that extreme values of transmission distortion are to be needed in
order for the incidence to increase as rapidly as it actually has done.
Maximum likelihood estimate for transmission parameter based on real data
Two models were fitted to the data: one with transmission probability fixed to 0.5 (M1)
and another where transmission probability was estimated (M2). When the two models
were compared using likelihood ratio test, model M2 fitted better (χ2=131.12, 1 df,
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p<0.001). The point estimate of transmission distortion was 0.86 and the estimated
genotype frequencies were (0.06, 0.37, 0.57). The observed and fitted incidence for both
models M1 and M2 of Type 1 diabetes are plotted in Figure 4, Publication II.
Conclusions
Fitting a population genetic model with non-Mendelian transmission as the sole factor
affecting changes in the incidence of Type 1 diabetes in Finland led to an estimate of the
transmission probability of 0.86. Such an extreme form of transmission distortion is
unlikely biologically. On the other hand, it is evident that a biologically reasonable
transmission distortion alone, even with the highest biologically reliable penetrances (eg
defined with respect to a major susceptibility allele, DR4 (DQ8) carrier, and non-carrier
genotypes) can only explain a small part of the rapid increase in the incidence of Type 1
diabetes observed in Finland. The observed increase could only be explained by realistic
non-Mendelian transmission rates if the relative penetrance differences of the
susceptibility genotypes were much greater than those known for DR4 (DQ8) today.
Based on these results, the role of other factors, probably environmental, in
modifying the disease incidence should be emphasized. Environmental factors could
either modify the penetrance of susceptibility gene(s), or act as triggering factors
contributing directly to the incidence. Factors which have changed rapidly during the last
few decades should be important in this respect, but none which have a well established
association with Type 1 diabetes are known. It has been hypothesized that changes in
penetrance might be linked to patterns of childhood immunization, but this has yet to be
confirmed (Blom et al 1991).
6.3 Transmission probability estimates based on DiMe data
Overall locus effects: HLA A, B, DR loci
The global tests for transmission patterns in the HLA A, B, and DR loci showed some
evidence for non-Mendelian transmission in the A locus for both maternal (p = 0.04) and
paternal (p = 0.04) alleles, as well as for the B locus on maternal side (p < 0.01) and
paternal side (p = 0.05). However, the transmission in the DR locus as a whole did not
deviate from Mendelian expectations.
The variation between the loci is somewhat surprising given that A, B and DR
loci are tightly linked to each other and are almost always transmitted together (the
recombination rate inside the HLA area is approximately 1% per generation). However, it
might imply that there is non-Mendelian transmission of some specific HLA haplotypes
or segregation in some specific genotypes.
Allele and sex specific effects
The paternal A26 allele and maternal A32 allele were transmitted less often than
expected. Also, segregation of alleles from paternal genotypes A28,A32 and A2,A3 may
not happen according to Mendel’s law. The paternal B38 allele and maternal B62 allele
were both transmitted at a lower frequency than expected. In the DR locus, the maternal
DR2 allele was inherited at a reduced frequency.
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Conclusions
The data do not provide direct support of the hypothesis of non-Mendelian inheritance of
alleles at the HLA A, B, and DR loci. Though some single allele transmission
probabilities differed significantly from 50%, these cannot be interpreted as conclusive
because corrections for multiple testing were not made. Generally, the existence of strong
non-Mendelian transmission can be ruled out. A comparison with estimates of
transmission given by other studies does not reveal any consistent pattern of non-
Mendelian transmission of any particular alleles.
6.4 Performance of HPM and QHPM
Simulated data with a dichotomous trait
The localization accuracy, which we call the fraction of data sets for which the
localization was successful as a function of the allowed localization error, was shown to
be good with the search parameters defined above (Figure 2a, Publication IV). For the
“easiest” data set, with A=10% of affected individuals carrying the susceptibility
mutation, the error made in prediction was less than 4 cM in 90% of all data sets. A clear
decrease in the power was seen in the data sets with 5% carrying the susceptibility allele,
and the method did not succeed much better than random guessing when only 2.5% of
affected carrying the mutation.
By doubling the sample size, but keeping otherwise all search parameters
constant, the localization accuracy improved significantly for low values of A (5%,
2.5%); for larger values of A there was not much difference (Figure 2b, Publication IV).
Thus, the localization accuracy did not depend that crucially on the fraction of disease
mutant carriers in the data, but more on the number of disease mutation haplotypes in the
data.
The tests with simulated errors in the data, as well as those with missing data,
showed that moderate proportions do not affect the localization accuracy at all (Figures
2c,d, Publication IV). Only the highest proportions tried, 10-20%, decreased the
localization accuracy by 10-15%. A comparison to two simpler association methods
(simple haplotype association, and haplotype patterns without gaps) showed that errors
and missing data were more detrimental to those approaches.
The robustness of the method with respect to the selection of pattern search
parameters, simulated data with A=10%, 1% corrupted and 20% missing, was re-
analyzed (Figure 2f, Publication IV). The effect of gaps in the patterns was evaluated by
either prohibiting gaps or by allowing the gaps to be up to three markers long instead of
just one. In addition, a test was run where the length of the haplotype patterns was not
limited. Differences started to appear at error bounds of at least 2 to 4 cM: allowing
longer gaps improved the performance somewhat, whereas prohibiting gaps altogether
resulted in a decreased performance.
Localization accuracy with permutation tests
Permutation tests were used to obtain more information about the significance of
observed marker scores. The experimental results obtained with 1,000 random
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permutations showed that the peaks observed in marker frequencies in the vicinity of DS
locus clearly surpassed those produced by background LD. The permutation surface for a
simulated data set with A=7.5% is shown in Figure 3a,b, Publication IV. The prediction
accuracy can be improved by permutation tests: We predicted the location of the DS gene
to be at the marker with the smallest p-value instead of the most frequent marker.
Optionally, given a threshold for the p-value, we made a prediction only if the best p-
value was below the threshold (and otherwise replied “don't know”). The localization
accuracy was somewhat improved by employing permutation tests (Figure 3d,
Publication IV, A=5%). The improvement was less evident with A=7.5%, and with
A=10% this modification had practically no effect. For A=2.5%, again, there was no
improvement with the sample size of 100 affected individuals.
Localization accuracy in SNP data
The results (Figure 4, Publication IV) show that the HPM method performs well with the
simulated biallelic data. For A=10% the accuracy is close to that of complete
microsatellite data, despite the 12.5% of missing data; with smaller values of A the
accuracy drops somewhat faster than with complete microsatellite data. Overall, the
localization accuracy with 3 SNPs per 1 cM in these data sets is close to that of a map
with one microsatellite per 1 cM.
Localization accuracy with HLA data
The results (Figure 5, Publication IV) demonstrate that the method was capable of
mapping the disease locus to the marker located closest to HLA-DQB1 and DRB1, that is
marker D6S2444, even though background LD in the HLA and the telomeric end of the
map was very strong. A comparison to the results of the Tsp analysis (Herr et al 2000)
shows that the mapping accuracy was similar with both approaches even though we used
less information for the HPM method.
Predicting the disease mutation site in the INS data set
Haplotype patterns with highest values of the χ2-measure are given in Table 5a. All
VNTR alleles were included in the Table 5a, whereas the VNTR class was used in 5b,
enabling us to differentiate between patterns of VNTR class association vs. VNTR allele
association. The algorithm includes sub-strings of long haplotypes thus yielding
redundant haplotype patterns. Still, the abundance of “1” alleles in the associated
patterns, especially in the middle of the region studied, was clear. All associated VNTR-
alleles belonged to class I. For some reason, strong associations were not found for any
alleles other than 655 and 714. The results were very similar for both parts of data we
had.
Marker-wise association scores were high but not very informative. The
association was strongest in markers 4 and 5, which are the VNTR and –23/HphI, but this
might be because scores are expected to be higher near the middle of region in any case.
Thus, the significance of the score was evaluated by a permutation procedure. The
permutation procedure was run with 10,000 iterations, which showed that the association
is strong through the whole region (Figure 9, below).
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Figure 9. Empirical p-values based on 10,000 permutations. Markers 1-8 are TH, -
2733A/C, -2221MspI, VNTR class, -23/HphI, +805/DraIII, +1127/PstI, +1428FokI,
respectively. All family trios were included in the analysis.
Protective haplotypes
Protective haplotypes were searched with the same approach, by simply swapping the
affected and control statuses in the data. In short, the haplotypes found were very similar
to those originally published by Bennett et al (1995): the patterns corresponding to
protective haplotype and very protective haplotype were strongly associated with being
unaffected. The very protective haplotypes were especially pronounced when the VNTR
class was used instead of alleles. The curves of markerwise scores were very similar to
those shown in Figure 9.
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Results in simulated quantitative trait data
The localization accuracy of the QHPM was analyzed with 100 replications of data in all
simulation settings: both the easy and the difficult models, with all five quantitative traits
Q1-Q5. The localization accuracy is illustrated by the cumulative percentage of data sets
in which localization error was the same or less than the given level (on X axis in Figure
3a,c, Manuscript V). Clearly, the simulated data varied from practically impossible to
very easy for this method.
Next, the QHPM approach was compared with basic-HPM. The quantitative traits
were dichotomized and basic-HPM analysis carried out for these new binary variables,
with the model M1 (difficult model), and all five quantitative traits. The dichotomization
was made by rearranging the data with respect to the values of quantitative trait to be
dichotomized, and then dividing the data into two equally sized parts. The half with lower
values was labeled as controls, and that with higher values as cases. The basic-HPM was
run with parameter settings χ2 -limit 6, maximum pattern length 7, and maximum number
and maximum length of gaps was 1.
The analysis of dichotomized variables, compared with quantitative analysis by
QHPM, led us to conclude that the probability of correct prediction is very similar with
both methods when the genetic effect on the trait is sufficiently high (Figure 4,
Manuscript V). However, when the genetic control of the trait decreases, the advantage of
the genuinely quantitative analysis becomes clear, the probability of correct prediction is
higher using QHPM than basic-HPM.
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7. Summary and conclusions
Research on complex diseases only seems to be approaching the final goal, the
prevention and cure of the diseases, very slowly. A wide spectrum of methodological
approaches will evidently be needed, including epidemiological, clinical, classical and
molecular genetical, and genetic epidemiological approaches. This thesis consists of the
application of a range of approaches, from a meta-analysis of incidence trends to
development and testing of new fine-mapping methods.
In the dissection of the genetic background of complex diseases it has become
evident that understanding of not only biological mechanisms but also the population
history, or population genetics, is crucial: the amount of allelic heterogeneity, the
proportion of “phenocopies”, and differences between populations are, in many respects,
a result of population processes. Mutation, drift, selection, and isolation shape the genetic
constitution of a population and thus the disease genetics. By understanding the behavior
of allele frequencies and haplotypes as a function of generations, it is easier to formulate
the expectations of what one can find in genetic marker data. What are the boundaries of
statistical methods for finding the genes with smaller and smaller effects?
Given the current stage of human genome mapping project, the almost complete
sequence of human genome, and the projects starting the evaluation of variability in
human populations, it is important to predict the needs of genetic researchers in a few
years. It can be anticipated that genotyping and analysis of candidate polymorphisms,
probably with SNP markers, will prevail. Mass genotyping with high-throughput
machinery, combined with efficient computational methods, is a direction in which
research seems to be going. Currently no one knows the population genetic structure of
inter-individual variability at the sequence level. The finding of a block structure in
Caucasian populations gives interesting insights, but is still far from being conclusive for
all genes – and non-Caucasian populations.
HPM
In the publication IV we were able to show that the algorithmic solution to the fine
mapping problem works well even with very small proportions of a mutant allele in the
affected sample. Thus, we believe that new hope for finding small effect loci can be
found in applying wholly new ways of thinking to the problem. In manuscript V, an
extension to quantitative traits was presented, which was shown to give good results with
simulated data. For the applicability of the methods themselves, it is very important to
note that in spite of them having been tested with simulated isolated population data, they
seem to work as well with data from large, even mixed ethnicities (UK, publication IV).
As fine mapping will take place over a smaller scale in future, there will be less need for
only using data from isolated populations; the structure of haplotypes at a very small
scale is dependent on ancient events. Thus, methods looking for shared haplotype
structure should function at that scale independently of the population history.
Regardless of the yet unsolved statistical problems, association studies in general
have recently been proposed as a powerful approach for detecting the several weak
genetic effects which underlie susceptibility to complex diseases (Risch and Merikangas
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1996, Lander 1996). Improved techniques for high-throughput identification and
genotyping of polymorphisms, such as SNPs, offer the possibility of using high numbers
of markers in genome screening and candidate gene scanning in the near future. The
density of such maps that is sufficient, given the population history of modern human
populations, is again strongly dependent on the population history (Reich et al 2001,
Kruglyak et al 1999, Long and Langley 1999).
We believe that the approach adopted here may be extendable to the analysis of
some of these complex characteristics. As a non-parametric approach the method has
unique properties compared to other LD methods. For example, it is conceptually rather
straightforward to extend the algorithm to find several genes simultaneously.
The method was modified to find two genes simultaneously and tested using simulated
data with two interacting genes and phenocopies. Both DS loci were reliably localized
(data not shown). The problem of multiple founder haplotypes (allelic heterogeneity at a
DS locus) is largely bypassed by simply counting separate patterns together in the marker
scores. The handling of marker inconsistencies, such as genotyping errors and mutations,
might be further improved by allowing approximate pattern matching in the haplotype
pattern discovery step. The proposed method also scales well to large data sets of biallelic
and multiallelic markers.
Finally, data mining methods might be used as a pre-processing step for more
detailed explicit statistical analysis. For example, the haplotype patterns might be used as
a sample space for the reconstruction of ancestral haplotypes in DS chromosomes. The
location of the DS gene, age of the mutation, and share haplotypes therein could be
estimated as the model parameters.
Increasing incidence
Even today, the factors which have been responsible for the increasing the incidence of
Type 1 diabetes, have not been identified. The Publications I and III comprise an effort to
understand the development of the incidence and to browse some of the hypotheses used
to explain the phenomenon.
Genetic factors have been shown to be important in the liability to Type 1 diabetes by
epidemiological methods by Kaprio et al (1992), Kyvik et al (1995), and Cordell and
Todd (1997). Although it is possible that the part of the population genetically
predisposed for Type 1 diabetes is in fact increasing, the evidence at hand shows that this
increase is modest and alone not a sufficient cause for the observed increase in incidence.
Changes in the genetic composition of the human populations are usually slow. In the
analysis of incidence trends in this Thesis, even the longest study period only covered 30
years, which is approximately the time period equal to one generation. It is very unlikely
that a 3 to 10-fold increase in incidence during such a short time could be result of
corresponding increase in the proportion of individuals with genetic susceptibility to
Type 1 diabetes. Instead, the penetrances of the susceptibility genes might be changing.
The penetrance is likely to be determined by an interaction between several susceptibility
genes and unknown environmental factors (Todd 1997).
During recent years much attention has been played to the identification and
possible control of environmental factors which may initiate or trigger the process
leading to Type 1 diabetes. Although some studies suggest associations between
environmental factors such as diet and viral infections with the risk of Type 1 diabetes
60
(Kostraba et al 1993, Dahlquist et al 1990, Virtanen et al 1994, Hyöty et al 1988, 1995,
Hiltunen et al 1995), their causative role in the aetiology of Type 1 diabetes has not been
shown. It is also difficult to show that any of these environmental factors has changed in
such a way that a continuous global increase in the incidence of Type 1 diabetes would be
easily explained.
In addition to Type 1 diabetes, the incidence and prevalence of several other
autoimmune diseases are known to be increasing. Already over ten years ago, a
“hygiene” hypothesis (Strachan 1989) was put forward: the microbial environment that
children in modern developed countries encounter does not include many of those
pathogenic organisms which have co-existed with human species for very long times. It is
possible that our immune system has adapted to encountering these antigens in a certain
developmental stage, and as that does not take place anymore the immune system gets
“misled” into attacking the body’s own molecules and cells. However, it is still an open
question as to why the attack is directed against specific cell types or not in all
individuals.
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